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FUNCIONALIZAÇÃO DE HIDROGÉIS DE NANOCELULOSE 
BACTERIANA PARA MIMETIZAÇÃO DE MICROAMBIENTE 
TUMORAL 
 
RESUMO 
O desenvolvimento de um sistema adequado de cultura de células em três 
dimensões (3D) para a seleção de fármacos anticâncer continua a ser uma 
necessidade não atendida. Um modelo 3D do microambiente tumoral 
simples, rápido, reprodutível e de baixo custo ainda não foi desenvolvido. 
Alterações do microambiente são fundamentais para a metástase e culturas 
em 3D podem ser utilizadas para estudar os mecanismos e efeitos que estas 
alterações causam na sinalização de células tumorais. O objetivo deste 
trabalho foi desenvolver modelos de bioengenharia para o estudo do 
comportamento de células endoteliais e células de melanoma que possam 
servir como matrizes para o rastreio de potenciais fármacos antitumorais. 
Primeiramente, hidrogéis de nanocelulose bacteriana (BNC) foram oxidados 
com HNO3/H3PO4-NaNO2, seguido por derivatização com um agente de 
acoplamento e finalmente, a heparina ou IKVAV foram imobilizadas sobre 
os hidrogéis através de ligações covalentes, funcionalizando assim esses 
biomateriais. O sucesso das imobilizações foi confirmado por técnicas de 
caracterização de materiais. As células endoteliais de veia umbilical humana 
(HUVECs) foram semeadas nas superfícies inferior e superior dos hidrogéis 
BNC e BNC-HEP e o comportamento celular foi observado. A superfície 
inferior do BNC-HEP é capaz de suportar a adesão celular, proliferação e 
induzir tubulogênese. Células de melanoma humano (SK-MEL-28) quando 
semeadas sobre as superfícies superior e inferior dos hidrogéis BNC e 
BNC-IKVAV adquiriram diferentes plasticidades tumorais como, por 
exemplo, o mimetismo vasculogênico. Os resultados aqui apresentados 
indicam que o comportamento celular pode ser controlado por interações 
simples com grupos funcionais em vez de biomoléculas solúveis ou 
materiais complexos, o que tornaria a produção de materiais para o estudo 
da angiogênese, mecanismos de invasão celular e mimetismo 
vasculogênico, mais baratos e facilmente controlados. Os biomateriais aqui 
desenvolvidos e estudados podem ser utilizados para a elucidação de 
diversos mecanismos celulares que levam à metástase tumoral. Assim, 
fármacos poderão ser testados contra diversas plasticidades celulares, 
visando o tratamento de câncer e de outras doenças de interesse biomédico. 
Palavras-chave: Nanocelulose bacteriana; microambiente tumoral; 
HUVECs; SK-MEL-28; plasticidades celulares; angiogênese; mimetismo 
vasculogênico.  
  
 
  
  
FUNCTIONALIZATION OF BACTERIAL NANOCELULOSE 
HYDROGELS TO MIMICKING OF TUMOR 
MICROENVIRONMENT 
ABSTRACT 
The development of a suitable system of three dimensions in cell 
culture (3D) for the selection of anticancer drugs remains an unmet need. A 
3D model of the tumor microenvironment simple, fast, reproducible and 
low cost has not yet been developed. Changes in the microenvironment are 
fundamental to metastasis and 3D cultures can be used to study the 
mechanisms and effects that these changes have on the signaling of tumor 
cells. The aim of this study was to develop bioengineering models for the 
study of endothelial cell behavior and of melanoma cells that can serve as 
matrix for the screening of potential anti-tumor drugs. First, hydrogels 
bacterial nanocelulose (BNC) were oxidized with HNO3/H3PO4-NaNO2, 
followed by derivatization with a coupling agent and finally heparin or 
IKVAV were immobilized on hydrogels by covalent bonds. The success of 
immobilization was confirmed by techniques for material characterization. 
Endothelial cells from human umbilical vein (HUVECs) were seeded in the 
top and bottom surfaces of hydrogels BNC and BNC-HEP and cell behavior 
was observed. The bottom surface of HEP-BNC is capable of supporting 
cell adhesion, proliferation and induce tubulogênese. Human melanoma 
cells (SK-MEL-28) when seeded on the upper and lower surfaces of 
hydrogels BNC and BNC-IKVAV acquired different tumor plasticities as, 
for example, vasculogenesis mimicry. The results presented herein indicate 
that the cellular behavior can be controlled by simple interactions with the 
functional groups instead of soluble biomolecule or complex materials. 
Thus, the production of material for the study of angiogenesis, cell invasion 
mechanisms and vasculogenesis mimicry can be easily controlled. 
Biomaterials developed and studied here may be used for the elucidation of 
many cellular mechanisms that lead to tumor metastasis. Thus, drugs can be 
tested against various cellular plasticity, targeting the treatment of cancer 
and other diseases of biomedical interest. 
Keywords: Bacterial nanocellulose; tumor microenvironment; HUVECs; 
sk-mel-28; cells plasticity; angiogenesis; vasculogenic mimicry. 
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1 INTRODUÇÃO 
De acordo com a Organização Mundial de Saúde (OMS) no ano 
de 2025 serão registrados mais de 20 milhões de novos casos de câncer 
(WORLD HEALTH ORGANIZATION; STEWART; WILD, 2014). A 
estimativa para o Brasil, referente aos anos de 2016‒2017, aponta a 
ocorrência de cerca de 600 mil novos casos da doença (INSTITUTO 
NACIONAL DE CANCER JOSÉ ALENCAR GOMES DA SILVA, 
2016). A proliferação secundária das células tumorais no que diz 
respeito à invasão de outros tecidos e órgãos é responsável pela maior 
parte dos óbitos de pacientes com câncer (BALTIĆ, 2006). 
A plasticidade das células tumorais está relacionada ao 
crescimento do tumor e a proliferação destas células através de um 
complexo mecanismo celular, conhecido como metástase tumoral 
(MARTIN et al., 2013). Durante a metástase as células tumorais 
invasivas modulam o próprio citoesqueleto com o objetivo de migrar 
por diferentes mecanismos e proliferar invadindo outros tecidos 
(JOYCE; POLLARD, 2009).  
Existem, ao menos duas vias de disseminação metastática uma 
delas dirigida por angiogênese e a outra denominada de mimetismo 
vasculogênico (FOLBERG; HENDRIX; MANIOTIS, 2000). Durante o 
aumento da massa tumoral, as células tumorais liberam moléculas 
sinalizadoras responsáveis pelo recrutamento de vasos sanguíneos que 
suprem a demanda de oxigênio e nutrientes necessários para a 
progressão tumoral (CARMELIET; JAIN, 2000; FOLKMAN, 1971). O 
recrutamento destes novos vasos sanguíneos a partir de vasos pré-
existentes se dá por meio de um processo denominado angiogênese 
(FOLKMAN, 1971a). As células tumorais migram para o interior destes 
vasos sanguíneos recrutados e são conduzidas para outros órgãos onde 
se alojam concluindo o processo metastático (VALASTYAN; 
WEINBERG, 2011). 
Outra via de disseminação tumoral acontece através de um 
mecanismo denominado mimetismo vasculogênico (MANIOTIS et al., 
1999a). No mimetismo vasculogênico as células tumorais assumem o 
comportamento de células endoteliais mimetizando os tubos vasculares 
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em busca de oxigênio e outros nutrientes para o crescimento do tumor. 
Desta forma, assim que as células tumorais acessam o endotélio vascular 
elas migram para o interior do vaso sanguíneo e depois para outros 
órgãos, assim como acontece na disseminação metastática por 
angiogênese (FOLBERG; HENDRIX; MANIOTIS, 2000; FOLBERG; 
MANIOTIS, 2004). 
Neste cenário, a busca de novos fármacos que possam combater 
os diversos mecanismos celulares que levam a metástase, se faz 
necessária. O desenvolvimento de um novo fármaco anticâncer custa 
aproximadamente 1 bilhão de dólares (LIGHT; KANTARJIAN, 2013), 
sendo que apenas 10% dos novos medicamentos para combater o câncer 
realmente tem sido eficaz, adicionando apenas algumas semanas ou 
meses para a vida de um paciente (HAIT, 2010). A baixa eficácia dos 
fármacos antitumorais é devida, principalmente, ao uso de modelos 
inconsistentes utilizados na realização dos testes pré-clínicos 
(GEVAERT, 2012).  
Sem dúvida, os componentes do microambiente desempenham 
um papel-chave na regulação destas vias de disseminação tumoral 
através de metástase (BISSELL; RADISKY, 2001). Assim, existe um 
esforço para substituir os métodos de rastreio convencionais, atualmente 
realizados em plataformas bidimensionais (2D). Neste sentido, a 
substituição das plataformas 2D por modelos tridimensionais (3D), que 
mimetizam o microambiente tumoral é de extrema relevância clínica 
(KIMLIN; CASAGRANDE; VIRADOR, 2013a, 2013b; YAMADA; 
CUKIERMAN, 2007).  
Devido à sua capacidade de simular a natureza da maior parte 
dos tecidos moles, os hidrogéis são materiais altamente atrativos para o 
desenvolvimento de matriz extracelular (MEC) sintética. Estas 
estruturas compostas de cadeias de polímeros reticulados possuem alto 
teor de água, fácil transporte de oxigênio, nutrientes, resíduos, bem 
como o transporte de fatores solúveis (NGUYEN; WEST, 2002). Além 
disso, os hidrogéis podem ser quimicamente modificados mimetizando a 
funcionalidade de moléculas sinalizadoras e direcionando o 
comportamento celular (DRURY; MOONEY, 2003; EL-SHERBINY; 
YACOUB, 2013b; VAN VLIERBERGHE; DUBRUEL; SCHACHT, 
2011; ZHU; MARCHANT, 2011). Entretanto, as matrizes de 3D de 
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origem animal comercialmente disponíveis, apresentam composição 
química indefinida, o que resulta em resultados não reprodutíveis 
(KLEINMAN; MARTIN, 2005). Devido à necessidade de se estudar o 
microambiente tumoral e desenvolver novos fármacos para combater a 
metástase, é necessário o desenvolvimento de modelos que consigam 
representar o ambiente tumoral como acontece in vivo (ASGHAR et al., 
2015; NYGA; CHEEMA; LOIZIDOU, 2011; OU; HOSSEINKHANI, 
2014; YAMADA; CUKIERMAN, 2007). Esses modelos precisam ser 
reprodutíveis, não ter a interferência de diversas moléculas nos 
resultados e ser de fácil uso. 
Desta forma, este trabalho propõe o desenvolvimento de duas 
plataformas 3D que possam ser utilizadas no rastreio de antitumorais 
eficientes na inibição da progressão tumoral. Dentre as plataformas 
desenvolvidas, a primeira baseou-se na imobilização de heparina nos 
hidrogéis de nanocelulose bacteriana provendo um microambiente capaz 
de induzir as células endoteliais a mimetizar a via metastática 
relacionada a angiogênese. A outra plataforma 3D desenvolvida baseou-
se na imobilização de um peptídeo derivado de laminina, o IKVAV 
(Isoleucina˗Lisina˗Valina˗Alanina˗Valina), nos hidrogéis de 
nanocelulose bacteriana com o intuito de induzir as células tumorais a 
mimetizar a via metastática do mimetismo vasculogênico e outras 
plasticidades no processo de invasão celular. 
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1.1 OBJETIVOS 
1.1.1  Objetivo geral 
 Funcionalizar hidrogéis de nanocelulose bacteriana para 
mimetizar o microambiente tumoral. 
1.1.2 Objetivos específicos 
 Funcionalizar hidrogéis de nanocelulose bacteriana (BNC) 
através da imobilização química de heparina (HEP); 
 Caracterizar a microestrutura dos hidrogéis BNC-HEP; 
  Analisar a citotoxicidade dos hidrogéis BNC-HEP; 
 Analisar o comportamento das células de veia endotelial 
humana (HUVECs) quanto a adesão e proliferação nos 
hidrogéis BNC-HEP; 
 Analisar o comportamento das HUVECs na mimetização da 
angiogênese quando cultivadas nos hidrogéis BNC-HEP; 
 Funcionalizar hidrogéis de celulose bacteriana (BNC) através 
de imobilização química do peptídeo IKVAV; 
 Caracterizar a microestrutura dos hidrogéis BNC-IKVAV; 
 Analisar a citotoxicidade dos hidrogéis BNC-IKVAV; 
 Analisar o comportamento das células de melanoma humano 
(SK-MEL-28) quanto a adesão, proliferação e morfologia nos 
hidrogéis BNC-IKVAV; 
 Analisar o comportamento das células SK-MEL-28 na 
mimetização do mimetismo vasculogênico nos hidrogéis BNC-
IKVAV. 
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1.2 ESTRUTURA DO TRABALHO 
Essa dissertação descrive a funcionalização de hidrogéis de 
nanocelulose bacteriana para mimetização de microambiente tumoral. A 
disseraão está organizada da seguinte maneira: 
 Capítulo 2 ‒ Revisão bibliográfica sobre o câncer e os 
mecanismos que levam a metástase tumoral. 
 Capítulo 3 ‒ Immobilization of heparin on bacterial 
nanocellulose hydrogels induces human endothelial cell 
tubulogenesis, que descreve a funcionalização de hidrogéis de 
BNC com heparina para o desenvolvimento de uma plataforma 
que mimetiza o ambiente tumoral na angiogênese. 
 Capítulo 4 ‒ A novel BNC‒IKVAV platform for vasculogenic 
mimicry and other plasticities of human melanoma cells que 
descreve a funcionalização de hidrogéis BNC com o peptídeo 
IKVAV para o desenvolvimento de uma plataforma que 
mimetiza o microambiente tumoral no processo de mimetismo 
vasculogênico. 
 Conclusões gerais sobre o trabalho. 
 
  
  
  
2 REVISÃO BIBLIOGRÁFICA 
2.1 CÂNCER 
O câncer pode ser definido como o crescimento anormal de 
células, causado por alterações na expressão de genes que conduzem a 
desregulação da proliferação e morte celular (HANAHAN; 
WEINBERG, 2011). A proliferação descontrolada de células anormais 
resulta na formação de uma massa tumoral. Os passos subsequentes da 
proliferação levam ao crescimento do tumor e, eventualmente, ao 
rompimento da barreira da membrana basal dos tecidos circundantes e 
assim, o câncer se espalha para outras partes do corpo, processo 
denominado de metástase (HEJMADI, 2010). 
A formação da metástase é dividida em várias etapas complexas 
chamadas de cascata de invasão da metástase. Nesse processo de 
invasão celular, as células tumorais primeiramente invadem a matriz 
extracelular local e as camadas do estroma celular e subsequentemente, 
o lúmen dos vasos sanguíneos e assim são transportadas através da 
vasculatura para tecidos distantes (GEIGER; PEEPER, 2009; JOYCE; 
POLLARD, 2009).  A metástase é em grande parte incurável 
devido à sua natureza sistêmica e a resistência das células tumorais aos 
agentes terapêuticos existentes. Mais de 90% da mortalidade por câncer 
é atribuível a metástases e não aos tumores primários (CHAFFER; 
WEINBERG, 2011; NGUYEN; BOS; MASSAGUÉ, 2009; WAN; 
PANTEL; KANG, 2013). 
Massas tumorais maiores que 180 µm são capazes de recrutar 
novos vasos sanguíneos, devido a necessidade de alta oxigenação 
tecidual, no processo denominado angiogênese (FOLKMAN, 1971a). 
Estas células, recrutam novos vasos sanguíneos para o local do tumor, 
através da liberação de fatores e citocinas angiogênicas e assim por meio 
desses novos vasos poderá ocorrer metástase (ADAIR; MONTANI, 
2010; CARMELIET; JAIN, 2000; FOLKMAN, 1971).  
Em determinados tumores, o processo de angiogênese não é 
suficiente para suprir as necessidades do tumor. Acredita-se que por esse 
motivo, um mecanismo independente de angiogênese está presente em 
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determinadas células tumorais agressivas, o mimetismo vasculogênico 
(FOLBERG; HENDRIX; MANIOTIS, 2000; FOLBERG; MANIOTIS, 
2004; MANIOTIS et al., 1999a). Este mecanismo é mediado através de 
plasticidade de células tumorais, que adquirem características de células 
endoteliais no processo de angiogênese. Assim, o mimetismo 
vasculogênico funciona como uma via adicional para a metástase 
(DÖME et al., 2007; FOLBERG; HENDRIX; MANIOTIS, 2000). 
2.1.1 Invasão celular 
O primeiro passo na metástase é a migração de células invasivas 
tumorais para o estroma, processo chamado de invasão tumoral. Os 
passos iniciais de invasão local incluem a ativação de vias de sinalização 
que controlam a dinâmica do citoesqueleto em células tumorais, seguido 
pela migração de células tumorais ativas para o tecido adjacente 
(FRIEDL; ALEXANDER, 2011; HULKOWER; HERBER, 2011; 
YAMAGUCHI; WYCKOFF; CONDEELIS, 2005). A metástase, ocorre 
em seguida quando as células tumorais invasoras se envolvem com 
vasos sanguíneos e linfáticos, penetram nas membranas basais e nas 
paredes endoteliais, e se disseminam através do lúmen dos vasos para 
colonizar órgãos distantes (GEIGER; PEEPER, 2009). 
A invasão tumoral requer maior motilidade celular 
impulsionada pela remodelação do citoesqueleto e contatos de células 
com a matriz extracelular, para isso as células tumorais tem a 
capacidade de se adaptarem a diferentes condições ambientais, 
assumindo diversas morfologias (plasticidade) e tipos de migração 
(FRIEDL; ALEXANDER, 2011; FRIEDL, 2004). 
Dois padrões principais de invasão de células tumorais têm sido 
descritos: a migração individual de células tumorais e a migração 
coletiva (FRIEDL; WOLF, 2003), conforme representado na Figura 1. 
As células que migram isoladamente ou em grupos podem se locomover 
através do modo ameboide ou mesenquimal. O modo ameboide de 
movimento é caracterizado pelo fenótipo redondo das células. Saliências 
celulares, geralmente posicionadas sobre a superfície das células, são 
reguladas pela dinâmica do citoesqueleto e são denominadas como 
bolhas (blebs) e geralmente estão presentes no modo de movimento 
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ameboide. Células ameboides são mais flexíveis e podem se espremer 
em pequenos espaços para se locomover, mas não são capazes de 
degradar a MEC ou gerar novos caminhos para o tumor 
(LÄMMERMANN; SIXT, 2009; WOLF et al., 2003). O modo 
ameboide parece ser preferido em situações de stress metabólico, tais 
como a hipóxia, o que pode implicar que o modo ameboide é menos 
consumidor de energia, ou mais eficiente em comparação com o modo 
mesenquimal (FRIEDL, 2004). No modo mesenquimal, o fenótipo 
celular é caracterizado por células com corpo celular alongado e longas 
saliências. Essas saliências são denominadas como invapodia, e 
degradam a MEC por interações e contatos célula-matriz (TSAI; 
YANG, 2013;KHALIL; FRIEDL, 2010).  
2.1.2 Angiogênese tumoral 
A angiogênese é a formação de novos vasos a partir de vasos 
pré-existente, processo subsequente a vasculogênese, formação de novos 
vasos sanguíneos in situ. A angiogênese é fundamental no 
desenvolvimento do tumor e requer a proliferação de células endoteliais, 
a migração de células através da MEC e interações célula-célula 
Figura 1. Células tumorais podem exibir dois modos diferentes de motilidade 
celular: modo mesenquimal e modo ameboide. O movimento mesenquimal 
requer a degradação da matriz extracelular (MEC), já as células com movimento 
ameboide migram de uma forma independente de integrina. Esses movimentos 
podem representar a migração coletiva ou isolada das células tumorais.  
 
Fonte: Adaptado de (MATSUOKA; YASHIRO, 2014) 
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(FOLKMAN, 1971). A Figura 2 representa o processo de angiogênese 
tumoral.  
Uma cascata de eventos deve acontecer para que a angiogênese 
ocorra, incluindo: liberação de fatores de crescimento pelas células 
tumorais, degradação da membrana basal, a ativação de células 
endoteliais (células tip), proliferação de células adjacentes (células stalk) 
e a formação de brotos de sólidos que formam o lúmen (tubulogênese) 
(HEJMADI, 2010).  
Primeiramente, as células de tumor expressam fatores pró-
angiogênicos, tais como o fator de crescimento endotelial vascular 
(VEGF), que se difundem para os tecidos circundantes e ligam-se a 
receptores nas células endoteliais dos vasos sanguíneos pré-existentes, 
levando à ativação das células (células tip). Essas interações entre as 
células endoteliais e células tumorais levam à secreção e ativação de 
várias enzimas proteolíticas, tais como metaloproteinases de matriz 
(MMPs), que degradam a membrana basal e a matriz extracelular. A 
degradação da membrana basal permite que as células tip migrem para o 
tumor. Células tip são células alongadas e caracterizadas pela presença 
de longos filamentos em uma de suas extremidades, chamadas de 
filapódio. Células stalk, células adjacentes à células tip, começam a 
proliferar e a seguir as células tip. Este processo resulta na formação de 
um broto capilar. As células tip não se dividem, já as células stalk 
proliferam, alongam o broto capilar e formam o lúmen. Esse processo de 
formação do lúmen é denominado tubulogênese. Para formar um loop (o 
lúmen formado na tubulogênese se dobra formando um laço), filapódio 
de células tip de diferentes brotos se conectam e estabelecem uma rede 
de vasos (DAVIS; SAUNDERS, 2006; DE SMET et al., 2009; 
SAMOLOV et al., 2005; STEEN et al., 1998). A Figura 3 mostra 
algumas das estruturas celulares presentes na angiogênese.  
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Figura 2. Etapas sequenciais da angiogênese tumoral. (1) O tumor dormente 
no começa a secretar fatores de crescimento angiogênicos. (2) Após as células 
endoteliais dos vasos circundantes são ativadas, começam a migrar e 
proliferam para o tumor. Uma célula tip guia a formação do broto vascular. (3) 
O novo broto forma um lúmen e o tumor é ligado a vasculatura, garantindo 
assim o crescimento e metástase do tumor (VAN HORSSEN; TEN HAGEN; 
EGGERMONT, 2006). 
 
 
Fonte: Adaptado de (VAN HORSSEN; TEN HAGEN; EGGERMONT, 
2006). 
 
Figura 3. Comportamento e estruturas celulares presentes no processo de 
angiogênese. 
 
 
 
 
 
 
 
 
 
 
 
Fonte: Adaptado de (WOOD; KAMM; ASADA, 2011) 
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2.1.3 Mimetismo vasculogênico 
O mimetismo vasculogênico foi introduzido em 1999 e 
descreveu a capacidade única de células de melanoma em formar canais, 
semelhantes a vasos, condutores de fluidos (MANIOTIS et al., 1999). O 
termo mimetismo vasculogênico é utilizado porque os canais não se 
formam a partir de vasos pré-existentes, apesar deles distribuírem 
plasma e conterem células vermelhas do sangue, mas possuem a 
capacidade em imitar a função dos vasos. Assim, o processo de 
mimetismo vasculogênico é a formação de canais, semelhantes a vasos, 
por células tumorais agressivas (HENDRIX et al., 2003). A Figura 4 
mostra o suprimento do tumor através da angiogênese e do mimetismo 
vasculogênico. 
As funções do mimetismo vasculogênico in vivo são de 
perfusão vascular, transporte de fluidos e nutrição, todos os requisitos 
críticos em estágios iniciais do crescimento tumoral. A caracterização 
morfológica das redes de mimetismo vasculogênico revelaram que estas 
são ricas em laminina extravasculares circundantes a esferoides de 
células tumorais (FOLBERG; HENDRIX; MANIOTIS, 2000; 
FOLBERG; MANIOTIS, 2004).  
Acreditasse que o processo de mimetismo vasculogênico ocorra 
porque o crescimento tumoral, muitas vezes, pode não ser totalmente 
suportado pelo processo de angiogênese (QIAO et al., 2015). Entretanto 
o mecanismo do mimetismo vasculogênico não é totalmente elucidado 
(LARSON et al., 2014). Mimetismo vasculogênico também foi relatado 
em tumores malignos não-melanoma tais como câncer da mama 
(SHIRAKAWA et al., 2001), de ovário (SOOD et al., 2001),sarcoma de 
Ewing (VAN DER SCHAFT et al., 2005) e pulmão (PASSALIDOU et 
al., 2002). A ocorrência de mimetismo vasculogênico é relativamente 
rara dentro tumores, mas sua presença está relacionada ao aumento do 
risco de metástase e portanto, má evolução clínica (PAULIS et al., 
2010). 
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Figura 4. Ação da angiogênese e mimetismo vasculogênico no tumor. Na 
angiogênese, células tumorais secretam fatores angiogênicos que induzem a 
formação de vasos até o tumor, para suprir suas necessidades. No mimetismo 
vasculogênico, as próprias células tumorais adquirem características de 
células endoteliais e formam tubos, semelhantes a vasos.  
 
Fonte: Adaptado de (MITCH LESLIE, 2016). 
2.2 TRIAGEM DE FÁRMACOS ANTICANCERTRIAGEM DE 
FÁRMACOS ANTICÂNCER 
O desenvolvimento de fármacos anticâncer envolve testes in 
vitro seguido por avaliação da eficácia desses medicamentos em ensaios 
clínicos (LIGHT; KANTARJIAN, 2013). A falta de bons modelos pré-
clínicos tem dificultado a descoberta de medicamentos anticâncer e sua 
implementação. Para enfrentar esses desafios, sistemas de cultura 3D 
são cada vez mais aplicadas no estudo da biologia do tumor 
(DEBNATH; BRUGGE, 2005). 
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Em metástase, as células tumorais invasivas precisam mudar 
sua organização do citoesqueleto e alterar contatos com matriz 
extracelular. Investigar como estas plasticidades contribuem com 
metástase e a migração no processo de invasão é uma maneira de 
desenvolver fármacos para combater a metástase (FRIEDL; 
ALEXANDER, 2011). 
Ao longo dos últimos anos, a terapia antiangiogênica tem sido 
uma estratégia promissora no tratamento de câncer (SHOJAEI, 2012). 
Os ensaios de angiogênese (in vitro) para o rastreio desses fármacos tem 
sido focados em testes de adesão, migração, proliferação e tubulogênese 
por células endoteliais em resposta a agentes inibidores ou 
estimuladores exógenos (JAIN, 2012). A observação de que células 
tumorais também podem formar redes tubulares e expressar fenótipo 
endotelial, sugeriu que inibidores da angiogênese poderiam inibir a 
formação de mimetismo vasculogênico em células tumorais. No entanto, 
o tratamento com inibidores da angiogênese não se mostrou eficaz para 
inibir o mimetismo vasculogênico em células de melanoma (VAN DER 
SCHAFT et al., 2004), sugerindo que essas células tumorais plásticas 
não adquirem sensibilidade aos mesmos fármacos utilizados na 
angiogênese. 
Durante muitos anos os modelos 2D têm sido utilizados como 
modelos pré-clínicos para o rastreio de fármacos com o objetivo de 
simular o microambiente in vivo. Entretanto, os fármacos não 
funcionam de forma eficaz in vivo como funcionam em plataformas 2D 
(BISSELL; RADISKY, 2001). Para superar as limitações presentes na 
estrutura 2D, um número crescente de estudos, estão sendo realizados 
em modelos 3D. Plataformas 3D mimetizam o microambiente in vivo 
devido a sua estrutura e assim induzem interações célula-célula e célula-
matriz. Características das células tumorais in vivo, tais como aumento 
da liberação de fatores de crescimento vascular, aumento da 
invasividade e potencial metastático, proliferação mais lenta, aumento 
da resistência a fármacos anticancerígenos são também comportamentos 
presentes em modelos 3D (BOND, 2005; LIANG et al., 2011; TAN; 
MARRA, 2010). 
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Muitas MEC comerciais, como Matrigel
®
 e Geltrex
®
 têm sido 
utilizadas como suportes 3D de células tumorais. Nessas matrizes de 
origem animal (sarcoma de rato) os principais componentes são 
laminina, colágeno IV, entactina, e proteoglicanos de sulfato de 
heparano e a composição de cada componente pode variar de lote para 
lote (HUGHES; POSTOVIT; LAJOIE, 2010; KLEINMAN; MARTIN, 
2005). Apesar dessas matrizes fornecerem pistas químicas e mecânicas 
essenciais para o comportamento celular, os resultados são 
frequentemente inconsistentes devido à variabilidade de lote para lote, 
composição química indefinida e manuseamento difícil do hidrogel 
(HUGHES; POSTOVIT; LAJOIE, 2010; KLEINMAN; MARTIN, 
2005). O desenvolvimento de novos sistemas de cultura 3D que 
simulam o microambiente extracelular do tumor pode ser apropriado 
para testar o comportamento de células de câncer e a sensibilidade das 
células tumorais e células endoteliais aos fármacos anticancerígenos. 
2.3 HIDROGÉIS 
Uma plataforma ideal deve proporcionar um ambiente 
adequado para a adesão, proliferação, diferenciação, migração e invasão 
celular (PEPPAS et al., 2006). Alternativamente, hidrogéis sintéticos 
têm sido utilizados como plataformas para permitir o crescimento de 
células tumorais e angiogênese de tumor, através da utilização de 
moléculas sinalizadoras na matriz. Os hidrogéis fornecem 
microambientes dinâmicos que se assemelham a MEC, para regular o 
destino da células através de interações célula-célula ou célula-
matriz(EL-SHERBINY; YACOUB, 2013a; MILLER et al., 2010).  
A MEC nativa é uma matriz fibrosa altamente complexa 
composta de proteínas (por exemplo colágeno, laminina, fibronectina, 
elastina), glicosaminoglicanos (por exemplo, ácido hialurónico, 
heparina), proteoglicanos (por exemplo, perlecano, sindecano), e fatores 
de crescimento e desempenha um papel crítico nos comportamentos 
celulares cruciais como diferenciação, proliferação, invasão e apoptose 
(KULAR; BASU; SHARMA, 2014). A MEC atua não só como uma 
estrutura de suporte mecânico para as células, mas também como um 
ambiente dinâmico bioativo e medeia as funções celulares (RHODES; 
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SIMONS, 2007). Assim a incorporação de moléculas bioativas em 
hidrogéis é uma importante estratégia para a fabricação de plataformas 
que mimetizem o ambiente in vivo (ZHU; MARCHANT, 2011). 
2.3.1 Nanocelulose bacteriana (BNC) 
A BNC é um hidrogel secretado por bactérias do gênero 
Gluconacetobacter como nanofibras hidrofílicos que se assemelha MEC 
nativa (RAMBO et al., 2008). BNC é composto por monômeros de 
glicose ligados por ligações β(1‒4) glicosídicas de fórmula química 
(C6H10O5)n, (PARK; PARK; JUNG, 2003). A estrutura do hidrogel de 
BNC lhe confere propriedades únicas, como a capacidade de retenção de 
água, resistência mecânica, a porosidade e a biocompatibilidade 
(KLEMM et al., 2011).  
O hidrogel de BNC formado em cultura estática é caracterizado 
por uma estrutura de rede fibrosa ultrafina 3D, contendo cerca de 99% 
de água (KLEMM et al., 2001). Quando BNC é produzido em 
condições estáticas, duas superfícies distintas são formadas. O lado que 
compreende a interface ar / líquido tem uma densidade mais elevada de 
fibra (superfície superior) e do lado oposto mostra uma menor densidade 
de fibras e uma superfície mais porosa (superfície inferior) (BERTI et 
al., 2013). Devido as propriedade deste material BNC extensivamente 
utilizado em aplicações da engenharia de tecidos (COLLA; PORTO, 
2014; CZAJA et al., 2007; KLEMM et al., 2001; RECOUVREUX et 
al., 2011; ZHIJIANG; GUANG, 2011). 
Algumas tentativas têm sido realizadas para combinar BNC 
com moléculas bioativas (BROWN; LABORIE; ZHANG, 2012; 
PERTILE et al., 2012) no entanto, a formação destes materiais 
dependem de ligações físicas (adsorção, revestimento, etc.). A 
imobilização eficaz de moléculas bioativas na estrutura BNC representa 
uma oportunidade interessante para explorar a sinalização molecular de 
BNC em células animais. 
Muitos autores descreveram hidrogéis de BNC como 
plataforma para liberação de fármacos (BODHIBUKKANA et al., 2006; 
SUEDEE et al., 2008; TROVATTI et al., 2012). No entanto, a 
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investigação do uso de BNC como um modelo tumoral tem sido muito 
limitada.  
Neste trabalho, imobilizamos duas diferentes moléculas 
bioativas na superfície de hidrogéis BNC, heparina e um peptídeo 
derivado de laminina, IKVAV. A heparina, um glicosaminoglicano que 
contém cargas aniônicas, tem sido utilizada devido a sua ampla 
afinidade com várias moléculas de sinalização. O uso da heparina no 
desenvolvimento de suportes para a engenharia de tecidos tem mostrado 
que os glicosaminoglicanos melhora significativamente a angiogênese 
(CAPILA; LINHARDT, 2002; RAJANGAM et al., 2006). O peptídeo 
IKVAV, derivado de laminina, tem sido relatado como um potente 
estimulador do crescimento do tumor, metástase, protease de 
ativação/secreção e angiogênese (ASSAL; MIE; KOBATAKE, 2013; 
HOSSEINKHANI et al., 2013). Além disso, o peptídeo IKVAV foi 
reportado como migração de células endoteliais e formação de rede 
tubular que ocorre através da interação com o receptor desconhecido na 
superfície de células de tumor (GRANT et al., 1992; KIBBEY et al., 
1994). 
  
3 IMMOBILIZATION OF HEPARIN ON BACTERIAL 
NANOCELLULOSE HYDROGELS INDUCES HUMAN 
ENDOTHELIAL CELL TUBULOGENESIS 
The work presented in this chapter was supported by the Brazilian 
National Council for Scientific and Technological Development (CNPq) 
and CAPES. The microscope images were obtained at the Central 
Laboratory of Electron Microscopy at the Federal University of Santa 
Catarina (UFSC). A manuscript with the results contained in this chapter 
is being prepared for submission. 
Abstract 
Models that mimic the angiogenesis initial processes, as 
adhesion, migration, proliferation and tubulogenesis, are extremely 
valuable for investigating the action of new anti-cancer drugs. There is 
still a need for an angiogenesis model that reflects in vivo environment, 
without the use of many factors that can interfere in the results. To 
address this challenge, we developed a 3D matrix well- defined based 
on covalently immobilization of heparin (HEP) on bacterial 
nanocellulose (BNC) hydrogels. First BNC hydrogel was oxidized with 
HNO3/H3PO4-NaNO2, followed by derivatization with 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC), and finally heparin was 
immobilized on the hydrogel by covalent bonds. Successful 
immobilization of the heparin into BNC hydrogel was confirmed by 
techniques for material characterization and through toluidine blue test 
was measured the amount of immobilized   haparin. Human umbilical 
vein endothelial cells (HUVECs) were seeded on bottom and top 
surfaces of hydrogels and cell behavior was observed. The bottom 
surface of BNC‒HEP is capable of supporting cell adhesion, 
proliferation and tubulogenesis induction. Results here presented 
indicate that the tubulogenesis induction can be controlled by 
interactions with bioactive molecule, heparin, instead of soluble 
biomolecule or complex materials, which would make the production of 
materials for study of      endothelial cells and drug screening, cheaper 
and more easily controlled. 
Keywords: Bacterial nanocellulose; heparin; human umbilical vein 
endothelial cells; angiogenesis; tubulogenesis 
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3.1 INTRODUCTION  
Cancer drug development costs approximately $1 billion [1], 
being that just 10% of new cancer drugs really has been effective, 
adding some weeks or months to a patient's life, rather than years [1, 2]. 
The low efficiency of the new cancer drugs has been related to the 
failure of pre-clinical screening and the inconsistent in vitro models 
used to predict in vivo drug response [2]. Two-dimensional (2D) in vitro 
models have been used as pre-clinic models to simulate the in vivo 
microenvironment [3–7]. However, 2D surfaces do not mimic the 
complex properties of three-dimensional (3D) microenvironment of 
tissues in vivo [4, 5]. The 3D extracellular matrices (ECM) have been 
used to resemble the in vivo environment, mimicking molecular and 
cellular signals able to regulate cell mechanisms, such as related to the 
tubulogenesis process, in the tumor angiogenesis [8, 9]. 
Angiogenesis, new blood vessels formation from the existing 
vasculature, is essential for tumor growth and metastasis [10]. Initially, 
tumor cells grow without blood vessels support, however with the 
increasing on the tumor size, cancer cells require nutrients to keep 
growing. Those nutrients are supplied by the recruitment of new blood 
vessels (bringing oxygen and other essential cell components) until the 
tumor site. The blood vessels recruitment arises when tumor cells 
release endothelial signals, such as angiogenic factors and cytokines. 
Those recruited blood vessels will be responsible to spread tumor cells 
in other tissues and organs by a mechanism knowing as metastasis [10, 
12]. Briefly, in the early recruitment of blood vessels, angiogenesis has 
been an attractive target for the development of novel anti-cancer drugs 
that could be able to block the migration of endothelial cell to cancer 
site avoiding the proliferation of tumor cells [13]. 
Angiogenesis assays (in vitro) have been used for the screening 
of anti-cancer drugs in some stages of angiogenesis, such as: endothelial 
cells adhesion, migration, proliferation and tube formation [14, 15]. 
Actually, tubulogenesis assay have been performed on 3D commercial 
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matrixes, as Matrigel
® 
(Corning), Cultrex
® 
(Sigma Aldrich) and 
Geltrex
® 
(Thermo Fisher Scientific), that reproduce tumor environment 
[16, 17]. However, the use of those commercial matrixes for cancer 
drugs screening produce inconclusive results due to their chemical 
variability from bacth-to-bacth which difficult the standartization of pre-
clinical tests [18]. Consequently, there is an urgent demand regarding to 
the development of 3D model platforms with a well-established 
chemical (minimal complexity) and microstructural properties that 
mimics the tumor ECM. Those 3D platforms could provide essential 
characteristics to direct and control the behavior related to several stages 
of cancer progression, as tumor tubulogenesis and tumor angiogenesis. 
Hydrogels have been widely used in tissue engineering and 
medicine regenerative applications, because their mechanical and 
structural properties could mimic the ECM of many human tissues [19]. 
Hydrogels surface modifications by the immobilization of bioactive 
molecules seems to be a strategy to control and guide interactions 
between cells and hydrogel surfaces [20, 21]. Bacterial nanocellulose 
hydrogels (BNC) have been synthesized during fermentation of bacteria 
from Gluconacetobacter genus [22]. On static fermentation the bacteria 
secrete BNC hydrogels containing two distinct surfaces [23]. BNC 
surface synthesized in the air/liquid interface has been characterized by 
a high density of fibers (named top surface) and the another surface 
presents higher porosity (named bottom surface) [24]. BNC hydrogels 
resemble ECM concerning important properties related to the 3D 
nanofibrous microstructure [24, 25]. From their interesting 
microstructure, BNC have been a promisor material for biomedical 
applications [26, 29].  
Structural ECM proteins (elastin, laminin, collagen and 
fibronection), growth factors (vascular endothelial growth factor 
(VEGF) and basic fibroblast growth factor (bFGF)), and 
glycosaminoglycans (GAGs) as heparin, hyaluronan and chondroitin 
sulfate have been associated as the components responsible for the 
induction of neovascularization by the recruitment of endothelial cells 
[30]. Heparin (HEP), a GAG component, holds anionic charges which 
have been related with a wide variety of signaling molecules that direct 
endothelial cell fate [31]. The use of heparin on the development of 
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tissue engineering scaffolds has shown that GAGs enhance significantly 
angiogenesis independent of the addition of other exogenous growth 
factors [32]. 
In this study, we propose to perform the chemical 
immobilization of heparin (HEP) on bacterial nanocelulose hydrogels 
(BNC) as an alternative to induce endothelial cells adhesion, 
proliferation which could provide an ideal microenvironment to 
endothelial cells organize themselves as tubulogenic networks on 
BNC‒HEP hydrogels. We pretend also explore the influence of 
BNC‒HEP hydrogels microstructure on endothelial cells behavior 
seeking for the development of a helpful platform to be used in the 
screening of anticancer drugs.  
3.2 EXPERIMENTAL 
3.2.1 Materials 
Reagents and chemicals were purchased from Sigma-Aldrich do 
Brasil Ltd. (São Paulo, SP). Culture media and supplements were 
purchased from Thermo Fisher Scientific do Brasil Ltd. (São Paulo, SP). 
Heparin (HEPAMAX-S
®
 sodium heparin - 5000 IU/mL) was supplied 
by Blau Farmacêutica S.A. (Cotia, SP). 
3.2.2 BNC‒HEP hydrogels synthesis 
3.2.2.1 Preparation of BNC hydrogels 
Gluconacetobacter hansenii (strain ATCC 23769) was used to 
produce BNC hydrogels. G. hansenii was cultured in a sterile medium 
composed of mannitol (25 g), yeast extract (5.0 g), and bactopeptone 
(3.0 g), diluted in 1 L of water and pH adjusted to 6.5. One hundred 
microliters of inoculum were locked into mannitol agar to form isolated 
colonies of bacteria, at 26 °C for 5 days. Thirty single colonies were  
inoculated into 6 mL of mannitol medium. Subsequently, 5 mL of 
inoculum were transferred to 45 mL of mannitol medium. Mixture was 
stirred and transferred to 24 wells plates (1 mL/well). After four days, 
on static culture conditions at 26 °C, hydrogels formed were removed 
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and purified in 0.1 M NaOH solution at 50°C for 24 h and then rinsed 
with distilled water to pH 6.5. Finally, the hydrogels were sterilized by 
autoclaving  (121 °C for 20 min) and kept refrigerated until used. 
3.2.2.2 Functionalization of BNC hydrogels with heparin 
Heparin was chemically immobilized on BNC hydrogels 
through an oxidation reaction with HNO3/H3PO4-NaNO2 [33] followed 
by derivatization with EDC [34]. Thirty milliliter of HNO3 (68% v/v) 
were mixed with 15 mL of H3PO4 (85% v/v) and 50 BNC were 
submersed in the solution. Subsequently, 0.63 g of NaNO2 was added 
and the mixture was stirred at the absence of light at room temperature 
for 24 h. BNC hydrogels were transferred into 0.2 % (w/w) of glycerol 
solution during 15 min to remove the residual oxidant. Finally, the 
samples were washed with acetone and air-dried for 30 min at 60 °C. 
Oxidized BNC (BNC-OX) were immersed in 45 mL of 0.1 M citrate 
buffer solution (pH 4.8) containing 2mM of EDC (1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide). Those hydrogels were shaking 
during 24 h at 4°C and after washed with deionized water. Samples were 
placed in citrate buffer (pH 4.8) containing 1000 IU heparin (v/v) for 24 
h at 4 °C with shaking. Finally, BNC‒HEP hydrogels were washed with 
alkaline phosphate buffered saline (PBS) and rinsed with distilled water. 
Hydrogels were lyophilized at -50 °C for 24 h to perform the chemical 
and microstructural characterization and they were sterilized by UV 
before to perform biological in vitro tests. 
3.2.3 Characterization of BNC‒HEP hydrogels 
3.2.3.1 Chemical characterization of BNC‒HEP hydrogels 
The functional groups on BNC and BNC‒HEP were analyzed 
by Fourier Transformed Infrared Spectroscopy (FTIR). Infrared spectra 
were recorded on an Agilent spectrophotometer (model Carry 600), with 
a  resolution of 4 cm
-1
, in a range of 4000-600 cm
-1
, and using 
attenuated total reflectance.  
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3.2.3.2 Determination of heparin content in BNC hydrogels 
Toluidine blue colorimetric assay was used to determine the 
amount of heparin immobilized on BNC‒HEP [35]. BNC‒HEP 
hydrogels were immersed in a solution containing 600 µL of toluidine 
blue and 300 µL of sodium chloride for 1 h at 37 °C. Afterwards, 
BNC‒HEP were removed from the container and 600 µL of hexane 
were added. The absorbance of the supernatant solution was measured at 
631 nm. The amount of heparin immobilized on BNC‒HEP hydrogels 
was quantitated in comparison with the calibration curve. 
3.2.3.3 Characterization of the surface area, pore volume and 
diameter pore distribution of BNC and BNC‒HEP 
hydrogels 
The N2 adsorption-desorption measurements were carried out at 
77 K with a liquid nitrogen trap according to the principle of static 
volumetric method for BNC and BNC‒HEP hydrogels by a 
Quantachrome NovaWin version 10.01. Surface area (SA) was 
calculated using Brunauer-Emmett and Teller (BET) equation and pore 
volume (PV) and pore diameter distribution (PD) were performed by 
Barrett–Joyner–Halenda (BJH) equation. 
3.2.3.4 Microstructural characterization of BNC‒HEP hydrogels 
Scanning electron microscope (SEM) was performed to analyze 
the microstructure of top and bottom surfaces of BNC and BNC‒HEP, 
using a JEOL JSM-6390LV microscope at 10 kV. For SEM analysis the 
hydrogels were frozen and lyophilized for 24 h. 
3.2.4 In vitro assays 
3.2.4.1 Cytotoxicity  
The cytotoxic potential of BNC‒HEP hydrogels were evaluated 
following the direct contact assay, according to ISO 10993-5: 2009 [36]. 
BNC hydrogels, non cytotoxic material [37], were used as control 
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group. Immortalized murine fibroblast cells (L929) were cultured in 
DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 
10% of FBS and 1% penicillin/streptomycin. L929 cells were seeded in 
each well of 24 wells culture plate at 9.0 × 10
3
 cells/cm
2
 for 24 h in a 
humidified atmosphere (5% CO2 in air) at 37 °C. After that, BNC and 
BNC‒HEP hydrogels were added into each well. After 1, 3 and 7 days 
of in vitro culture, the metabolic activity of L929 cells were determined 
by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2-
(4-sufophenyl)-2H-tetrazolium] colorimetric assay from Promega 
Biotecnologia do Brasil, Ltda. (São Paulo, SP), performed according to 
the manufacturer’s instructions. The plates were kept in a humidified 
atmosphere (5% CO2), incubated at 37 °C during 2 h protected from 
light. Absorbance of supernatants solutions were measured at 490 nm 
using Micro ELISA reader. 
3.2.4.2 HUVECs adhesion on BNC and BNC‒HEP hydrogels 
Immortalized human umbilical vein endothelial cells 
(HUVECs) were maintained in RPMI-1640 medium supplemented with 
10% FBS, 1% penicillin/streptomycin. HUVECs were seeded at a 
density of 5.2 × 10
4
 cells/cm
2
 on the top and bottom surfaces of BNC 
and BNC‒HEP. HUVEC cells were allowed to attach during 4 h on the 
hydrogels surface kept on a humidified atmosphere containing 5% of 
CO2 at 37 °C. After 4 h, MTS solution was used to quantify the number 
of metabolically active cells adhered on the hydrogels surface. 
Qualitative assays were also performed and the adherent cells were 
fixed with 4% formaldehyde for 30 min and permeabilized with 0.1% 
Triton X-100 for 5 min at room temperature. To visualize F-actin, cells 
were stained with Alexa Fluor 546 conjugated to phalloidin and cell 
nuclei were stained with 4',6-diamidino-2-phenylindole dihydrochloride 
(DAPI). The HUVECs morphology on the early stage of contact 
between cells-hydrogels was analyzed by confocal laser scanning 
microscopy (CLSM, Leica DMI6000 B, Leica Microsystems, 
Mannheim, Germany). 
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3.2.4.3 HUVECs Proliferation and morphological behavior on 
BNC and BNC‒HEP hydrogels 
Proliferation and behavior were analyzed after 1, 2, 3 and 7 
days of in vitro culture of HUVEC cells seeding (5.2 × 10
4
 cells/cm
2
) on 
the both surfaces of BNC and BNC‒HEP. After 1, 2, 3 and 7 days, MTS 
assay was used to quantify the proliferation of metabolically active cells 
on BNC and BNC‒HEP surfaces. The morphological behavior of 
HUVECs cultured on hydrogels surfaces were also observed by 
confocal microscopy (Leica DMI6000 B, Leica Microsystems, 
Mannheim, Germany). For that, HUVECs were fixed and stained with 
Alexa Fluor 546 conjugated with phalloidin and DAPI. After 7 days of 
in vitro culture, z-stack images were obtained at 2 x amplification 
assuming z-spacing of 3 µm per slice and compiled as projections to 
observe HUVECs distribution over BNC and BNC‒HEP surfaces. 
3.2.4.4 Tubulogenesis induction 
HUVECs were seeded at a density of 105 cells/cm2 on the 
bottom surface of BNC‒HEP hydrogels. Samples were incubated for 24 
h in a humidified atmosphere containing 5% of CO2 at 37 °C. After 24 
h, samples were fixed with 4% of formaldehyde for 30 min at room 
temperature. Phase contrast images were taken using an Olympus BX4 
microscope (Olympus America Inc.). 
3.2.5 Statistical analysis  
Data were statistically by one-way analysis of variance 
(ANOVA) with Tukey test. Values represent the mean ± standard 
medium error, with p< 0.05. All experiments were performed in 
triplicate at two separated experimental times. 
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3.3 RESULTS 
3.3.1 Functionalization of BNC hydrogels 
Figure 1 shown a scheme illustration of the oxidative reaction 
used to immobilize heparin on BNC hydrogels. BNC were oxidized to 
convert free hydroxyl groups of BNC in carboxyl groups (Fig. 1a). 
Those carboxyl groups were activated with EDC allowing the covalent 
immobilization of heparin (Fig. 1b).  
 
Figure 1. Immobilization reaction of heparin in BNC hydrogels. (a) 
Oxidation process with HNO3/H3PO4-NaNO2 to convert the free hydroxyl 
groups of BNC to carboxyl groups, resulting in oxidized BNC (BNC-ox) in 
the carbon C6. (b) Activation of the carboxyl groups present on the BNC-ox 
with EDC (coupling agent). Followed by the covalent reaction between 
active carboxyl groups on BNC-ox and the amine groups of the heparin, 
resulting in BNC-HEP hydrogel. 
 
 
FTIR spectra comproved the presence of heparin on BNC‒HEP 
(Fig. 2). Characteristic bands of BNC appeared at 3345 cm−1 and 2898 
cm−1, where the absorption band assigned to hydroxyl groups and 
hydrogen bonds, respectively [35]. BNC‒HEP showed a broad 
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absorption at 3100–3500 cm-1 which was assigned to N–H stretching 
absorption and hydrogen bonded hydroxyl groups; other heparin 
characteristic bands were observed at 1701 cm−1 (C=O ) and 1248 cm-1 
(S=O) [38–40]. The amount of heparin immobilized on BNC hydrogels 
was quantified by toluidine blue dye assay which revealed a density of 
immobilization of 4.7 μg ⋅cm-2, approximately 1% of BNC dry weight. 
Figure 2. FTIR spectroscopy of BNC and BNC-HEP hydrogels. FTIR 
spectra of BNC with characteristic groups hydroxyl (OH) and alkanes 
(CH). BNC-HEP heparin immobilized BNC with groups characteristic of 
heparin as carbonyl (C=O), sulfonic (S=O) and hydroxyl (OH). 
 
 
The average of pore diameters distribution (PD), surface area 
(SA), pore volume (PV) were quantified by nitrogen structure 
adsorption–desorption. BNC and BNC‒HEP showed a similar PD 
average, ranging from 3.5-30.3 nm to BNC and 3.5-30.8 nm to 
BNC‒HEP. The values   obtained to SA and PV were shown in Table 1. 
In comparison to the BNC, SA and PV of BNC‒HEP decreased 
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approximately 14% and 11%, respectively, after heparin 
immobilization. 
Table 9. Surface area (SA) and pore volume (PV) of BNC and BNC-HEP 
hydrogels. 
 
 
SEM micrographs related to the top and bottom surfaces of 
BNC and BNC‒HEP hydrogels were shown in Figure 3. BNC hydrogels 
were characterized by an entangle arrangement of BNC fibers on top 
surface and with a porous arrangement of fibers on the bottom surface 
according with described in the literature (Fig. 3a). The top surface of 
BNC‒HEP (Fig. 3d) kept the same microstructure observed on the top 
surface of BNC (Fig. 3b). Moreover, the bottom surface of BNC‒HEP 
showed a similar microstructure observed on the bottom surface of BNC 
(Fig. 3a). 
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Figure 3. SEM micrographs of freeze-dried BNC and BNC-HEP samples. (a) 
bottom surface BNC, (b) top surface BNC, (c) bottom surface BNC-HEP and 
(d) top surface BNC-HEP. 
 
 
 
55 
 
 
 
3.3.2 Cytotoxicity  
Direct contact between L929 cells and BNC‒HEP hydrogels 
showed that those materials did not induce any cytotoxic effect on L929 
cells during 7 days of in vitro culture. The metabolic activity of L929 
cells cultured on contact direct with BNC‒HEP hydrogels were 96% (1 
day), 111% (3 days) and 108% (7 days) compared to BNC hydrogels 
(100%) (Fig. 4). Significant differences were not observed when 
compared the metabolic activity of L929 cells cultured on contact direct 
with BNC and BNC‒HEP hydrogels. 
Figure 4. Metabolic activity of L929 cells after direct contact with BNC and 
BNC-HEP hydrogels, during 1, 3 and 7 days. BNC hydrogels was used as 
reference (100%).  
 
 
 
3.3.3 HUVECs adhesion on BNC and BNC‒HEP hydrogels 
HUVECs were seeded on the top and bottom surfaces of BNC 
and BNC‒HEP to quantify the number of metabolically active cells 
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adhered on the hydrogels surfaces. After 4 h of seeding, there were 
232% more HUVECs adhered on the top surface of BNC‒HEP than on 
the same surface of BNC. On the bottom surfaces, the adhesion of 
HUVECs was 71% higher on BNC‒HEP than on the same surface of 
BNC (Fig. 5). 
Figure 5. Percent adherent HUVECs metabolically active on both surfaces on 
BNC-HEP hydrogels during 4 h. BNC hydrogels was used as reference (100%). * 
significantly diferente, p<0.05. 
 
 The morphology of HUVECs cultured on BNC and BNC‒HEP 
was evaluated by CLSM images in the early contact (4 h) between cells 
and hydrogels (Fig. 6). HUVECs were adhered on BNC and BNC‒HEP 
surfaces and they showed a predominantly rounded morphology. Solely, 
on the bottom surface of BNC and BNC‒HEP was possible to observe 
some spreaded cells (Fig. 6a, b). On the top surface of BNC and 
BNC‒HEP any spreaded cells were observed (Fig. 6d). 
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Figure 6. CLSM images of HUVECs cultivated after 4 h on the bottom and top 
surfaces of BNC and BNC-HEP. HUVECs were stained with Alexa Fluor 546 
conjugated to phalloidin (red) and DAPI (blue). (a) HUVECs on the bottom 
surface of BNC, (b)HUVECs on the top surface of BNC, (c) HUVECs on the 
bottom surface of BNC-HEP and (d) HUVEC cells on the top surface of BNC-
HEP. 
 
3.3.4 Proliferation and morphology of HUVECs on BNC and 
BNC‒HEP hydrogels 
MTS assay was performed after 1, 2, 3 and 7 days of HUVECs 
cultured on the top and bottom surfaces of BNC and BNC‒HEP 
hydrogels to analyze the influence of chemical surface and 
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microstructure of those hydrogels on HUVECs proliferation and 
morphology. An increase on the number of HUVECs metabolically 
active was observed when cells were cultured on both surfaces of 
BNC‒HEP compared to BNC (Fig. 7). There were significant 
differences on the number of proliferative HUVECs cultured on the top 
surface of BNC compared to top surface of BNC‒HEP. The 
proliferation of HUVECs on the top surface of BNC‒HEP were 126% 
(1 day), 75% (2 days), 85% (3 days) and 102% (7 days) higher than on 
top surface BNC (100%). On the bottom surfaces, HUVECs showed a 
similar proliferative profile when cultured on BNC and BNC‒HEP until 
three days of culture. Significant differences on bottom surfaces were 
observed just after 7 days of culture where HUVECs showed an increase 
on the number of proliferative cells (9%) on the bottom surface of 
BNC‒HEP compared to bottom surface of BNC. 
 
Figure 7. HUVECs metabolic activity on BNC and BNC-HEP during 7 days. 
 
HUVECs morphology was investigated by confocal microscopy 
during the 7 days of culture on BNC and BNC‒HEP. HUVECs cultured 
during 1 day on the bottom surfaces of BNC and BNC‒HEP were 
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elongated and interconnected (Fig. 8a, d). Moreover, HUVECs began to 
align on the bottom surface of the BNC‒HEP (Fig. 8d) and at the end of 
two days of culture those cells were completely aligned and arranged as 
tubulogenic networks (Fig. 8e). On the third day of culture HUVEC 
cells still proliferative increasing the number of cells and covering the 
entire on the bottom surface of BNC‒HEP (Fig. 8f). Tubulogenic 
networks formation were not observed on the bottom surface of BNC 
over 3 days of culture (Fig. 8a-c). HUVECs cultured on the top surface 
of BNC and BNC‒HEP did not organized themselves as tubular 
networks and those cells adhered with a rounded morphology over the 
first three days of culture. On the top surface of BNC‒HEP was possible 
to observe a higher number of HUVECs compared to top surface of 
BNC (Fig. 8j-l). After 1 day of culture, HUVECs formed a monolayer 
that covered the entire top surface of BNC‒HEP (Fig. 8j). On the second 
and third day of culture, HUVECs formed multilayers on top surface of 
BNC‒HEP hydrogels (Fig. 9k, l). The top surface of BNC showed a 
lower number of proliferative HUVECs compared to BNC‒HEP (Fig. 
8g-i). 
On seventh day of culture, HUVECs formed multilayers on 
both surfaces of BNC and BNC‒HEP. In Figure 9 is possible to observe 
the migration and arrangement cell into hydrogels and cell 
multilayerformation. Due to cell growth in seven days was no longer 
possible to observe similar structures angiogenesis in the bottom surface 
of BNC-HEP (Fig. 9e-h). In the bottom surface of BNC hydrogels, 
HUVEC cells continued elongated although in the multilayer cells (Fig. 
9a-d). Top surface of BNC-HEP shows the cells multilayer occupying 
all hydrogel. In addition, it is possible to observe the presence of 
elongated cells and well cell aligned on the hydrogel (Fig. 9i-l). Top 
surface of BNC showed few cells sprawling in the seventh day of 
culture, and rounded morphology prevailing over the seven days of 
growth (Fig. 9m-p). 
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Figure 8. CLSM images of HUVECs cultivated on the bottom and top surfaces of BNC 
and BNC-HEP hydrogels during 3 days. HUVECs were stained with Alexa Fluor 546 
conjugated to phalloidin (red) and DAPI (blue). (a-c) HUVECs on the bottom surface of 
BNC over 1, 2, and 3 days, respectively, (d-f) HUVECs on the bottom surface of BNC
-
HEP over 1, 2 and 3 days, respectively, (g-i) HUVECs on the top surface of BNC over 
1, 2 and 3 days, respectively and (j-l) HUVECs on the top surface of BNC-HEP over 1, 
2 and 3 days, respectively. 
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Figure 9. HUVECs interactions into hydrogels on seventh day. The projections 
were taken at 3 µm per slice. (a-d) HUVECs on the bottom surface of BNC. 
Depth of images are 30.5, 15.6, and 3.6 µm, respectively. (e-h) HUVECs on the 
bottom surface of BNC-HEP. Depth of images are 0.9, 11.9, and 19.9 µm, 
respectively. (i-l) HUVECs on the top surface of BNC. Depth of images are 
39.7, 15.8 and 3.8 µm, respectively. (m-p) HUVECs on the top surface of BNC
-
HEP. Depth of images are 15.4, 5.4, and 20.3 µm, respectively. 
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3.3.5 Tubulogenesis induction 
HUVECs were able to interconnect and aligne theirselves when 
cultured on the bottom surface of BNC‒HEP. Then, a larger amount of 
HUVECs (10
5
) were sow on the bottom surface of BNC‒HEP, to form 
more tubulogenesis established patterns. After 24 hours of culture, 
HUVECs were aligned and organized as tubulogenic networks on the  
bottom surface of BNC‒HEP (Fig. 10 and 11). In detail, Figure 10 
showed the formation of endothelial tubulogenic networks containing 
loops and branch points. Figure 11 showed the presence of endothelial 
tip cells, characterized by cell protrusions called filopodia. Following 
the endothelial tip cells were observed endothelial stalk cells. 
 
Figure 10. Phase contrast images of tubulogenesis process of HUVECs 
cultured on the bottom surface of BNC-HEP after 24 h. Red arrows indicate 
branching points and the loops are represented by red rings. Scale bars 
represent 100 µm.  
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Figure 11. Phase contrast images of tubulogenesis process of HUVECs 
cultured on the bottom surface of BNC-HEP after 24 h. Red arrows indicate 
tip cells. Stalk cells are represented by rings. Scale bars represent 100 µm. 
 
 
3.4 DISCUSSION  
The evaluation of the effectiveness of anti-tumor drugs must be 
investigated by several phases of pre-clinical trials [42]. One of the main 
phase of the pre-clinical-trial has been related to the ability of a specific 
anti-tumor drug inhibit the formation of blood vessels (angiogenesis 
assays) by the tumor cells. Moreover, pre-clinical trial phases also 
investigate the endothelial cell behavior analyzing their potential to 
adhere,  migrate, proliferate and form vessel tubes [43]. Actually, in 
vitro models of pre-clinical-trials have been doing using 2D cell culture 
plates or commercial ECM extracted from tumor of murine 
(tubulogenesis assay) which not mimic the in vivo tumor 
microenvironment. Commercial ECM have been associated with 
chemical variations from batch to batch [16]. In this context, we propose 
the development of a novel 3D tubulogenesis platforms with no 
chemical stability and variation to perform the screening of anti-tumor 
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drugs to affect the recruitment of vascular blood vessels and also to 
study the behavior of endothelial cells (adherence, proliferation and 
migration), subsequently. A novel 3D platforms were successfully 
developed by the immobilization of heparin (HEP) on BNC hydrogels.  
BNC‒HEP hydrogels were produced by an oxidative reaction 
[33] where heparin was covalently bonded on the carboxyl group of 
BNC. The chemical immobilization of HEP were confirmed by FTIR 
analysis through the presence of characteristic bands (C = O and S = O). 
Hydrogels that contain porous surface have been related as an ideal 
surface for HUVECs culture [44]. Based on distribution of pores 
diameters BNC and BNC‒HEP were classified as mesoporous polymers 
(sizes between 2 to 50 nm) [41]. Mesoporous hydrogels have been 
highlighted in tissue engineering applications, since the pores in the 
nanometer range could support cell adhesion and proliferation [45]. The 
surfaces areas found on BNC and BNC‒HEP were over than 100 m²/g 
which were the highest surface area found in the literature (from 12.3 to 
22.8 m
2
/g) [46, 47]. We believe that the genus of the bacteria used to 
produce BNC hydrogels and also the fermentation time were important 
parameters to support those surface area value to BNC.   
SEM micrographs revealed microstructural differences between 
bottom and top surface of BNC agreeing with the observations already 
published [23, 38, 46, 48]. Yizao Wan and collaborators (2011) 
adsorbed (immersed on HEP solution) heparin on BNC hydrogels, 
however they did not observed any microstructural difference between 
BNC and BNC functionalized with heparin [38]. Those results 
suggested that the oxidation process used in our work to immobilize 
chemically HEP may changed the microstructure of BNC‒HEP. As 
result we found that the immobilization of HEP by oxidative reaction 
became the bottom surface of BNC‒HEP more porous than BNC. 
Based on our results we found that BNC and BNC‒HEP were 
no cytotoxic hydrogels for tissue engineering applications through ISO 
10993-5: 2009 [29]. The cytotoxicity potential of BNC hydrogels was 
also evaluated by Saska et al., (2012) which demonstrated absence of in 
vitro cytotoxicity effects caused by BNC [37]. Other authors also tested 
the cytotoxicity BNC-chitosan hydrogels functionalized with heparin, 
and those materials were not cytotoxic [38]. Our results also showed 
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that the immobilization of heparin was not cytotoxic to L929 cells. BNC 
and BNC‒HEP were used to investigate the behavior of HUVECs 
cultured on both surfaces of those hydrogels. BNC‒HEP hydrogels 
promoted an increasing on cell adhesion when compared to BNC. 
Bottom surface of BNC‒HEP showed 70% more HUVECs adhered 
compared to the same surface of BNC. When HUVECs were cultured 
on the top surface of BNC‒HEP they adhered twice more compared to 
the top surface of BNC. In addition, there were no significant 
differences between the number of adhered cells on the top and bottom 
surfaces of BNC (p <0.05). Top and bottom surfaces of BNC‒HEP were 
able to support and increase the number of HUVECs adhered. However, 
after 4 h of seeding, the bottom surfaces of both hydrogels were able to 
induce the spreading of HUVECs. The increasing on the number of 
adhered HUVECs must be related to heparin immobilization on BNC 
hydrogels. When HUVECs were cultured with heparin as a component 
of culture medium, they also showed an increasing on the expression of 
gene related to cell adhesion [49]. 
An increasing on HUVECs proliferation was observed when 
these cells were cultured on the both surfaces of BNC‒HEP. The 
number of proliferative HUVECs on the bottom surfaces of BNC and 
BNC‒HEP were significantly different only after 7 days of culture. 
HUVECs behavior were completely dependent of the surface of 
seeding. HUVECs cultured on the top surfaces of BNC and BNC‒HEP 
were morphologically rounded. Unlike, HUVECs cultured on the 
bottom surfaces of BNC and BNC‒HEP were elongated and they 
maintained cell-cell interactions. We noted that HUVECs cultured on 
the bottom surface of BNC‒HEP were able to contact themselves and 
they were aligned in network-like. 
Tubulogenesis assays have been usually carried out by seeding 
endothelial cells on a commercial ECM (ECM from animal origin, such 
as Matrigel
®
 or Geltrex
®
) [16, 50]. Cell behavior as tubes, branch points 
and loops have been used to quantify tubulogenesis process [50]. When 
10
5
 cells/cm
2
 HUVECs were seeded on the bottom surface of 
BNC‒HEP, these cells auto-organize themselves as vascular networks, 
tubulogenesis.  
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After 24 h, HUVECs cultured on the bottom surface of 
BNC‒HEP formed a well-organized vascular network containing 
several capillar sprouts. Capillary sprouts have been composed by the 
presence of endothelial tip and stalk cells. Endothelial tip cells 
coordinate cells alignment through the filapodios that produce attractive 
and repulsive directional signals being the most important phenotype to 
direct branch points, interconnectivity and functionability to the vascular 
network The endothelial tip cells were followed by aligned proliferative 
cells, denominated stalk cells [51, 52]. Endothelial stalk cells 
established adherent points and tight junctions to ensure the endothelial 
stability required to form the nascent vascular lumen [53]. The presence 
of endothelial stalk cells indicate high cell proliferation on BNC‒HEP. 
Endothelial branch points and loops have been essential on 
tubulogenesis process. The analysis of the number of branch points and 
loops of in vitro assays provided an useful measurement of the 
outgrowth and extension of pre-angiogenesis network [54]. 
Commercial ECM contain many pro-angiogenic factors which 
make it difficult to assess the real influence of drugs on the 
tubulogenesis process [50]. In addition, tubulogensis formed on those 
commercial ECM have been reported as quite homogeneous in length 
and shape which not represent angiogenesis in vivo [55]. The same 
problem was also observed on artificial matrices where several 
molecules were used to signalize tubulogenesis to HUVECs [30, 56, 
58]. Here, we produced a 3D platform based on BNC‒HEP hydrogels 
that induce tubulogenesis on human endothelial cells. Further 
investigations will be performed to analyze the influence of known 
anticancer drugs on the tubulogenesis formed on BNC‒HEP hydrogels. 
Thus, our results showed some evidences that BNC‒HEP hydrogels 
could be used to overcome the problems actually found in the current 
tubulogenesis platforms. 
Finally, our results proved that not only the presence of HEP 
was important to signalize the HUVECs to form the vessel tube 
network, but also the microstructure of BNC. Our results reinforce the 
idea that chemical and physical fields should be considered on the 
design of novel tissue engineering constructions.  
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3.5 CONCLUSIONS 
The BNC‒HEP hydrogels were obtained via covalent 
bondsbetween heparin and oxidized BNC. The behavior of cultured 
HUVEC cells on both surfaces (top and bottom) of the BNC and 
BNC‒HEP hydrogels was dependent on the microstructure and 
chemical composition these materials. Top surface of BNC‒HEP was 
able to increase the adhesion and proliferation of HUVEC cells 
compared to BNC. Morever, bottom surface of BNC‒HEP was able to 
induce tubulogenesis in HUVEC cells after 24 h culture. Thus, 
BNC‒HEP was able to induce early stages of angiogenesis in HUVECs, 
with the use of only a bioactive molecule,   heparin. The use of this 
material as a screening anti-angiogenic can overcome the difficulties in 
obtaining reliable results in this animal platforms currently available. 
Furthermore, BNC‒HEP hydrogels are readily available material, 
reproducible and inexpensive. 
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4 A NOVEL BNC‒IKVAV PLATFORM FOR 
VASCULOGENIC MIMICRY AND OTHER PLASTICITIES 
OF HUMAN MELANOMA CELLS 
The work presented in this chapter was supported by the Brazilian 
National Council for Scientific and Technological Development (CNPq) 
and CAPES. The microscope images were obtained at the Central 
Laboratory of Electron Microscopy at the Federal University of Santa 
Catarina (UFSC). A manuscript with the results contained in this chapter 
is being prepared for submission. 
Abstract 
Invasive melanoma cells involved in the metastasis process 
usually change their cytoskeletal organization to interact with the 
surrounding extracellular matrix (ECM). In the metastatic migration, 
tumor cells adopt distinct shapes, which have been related to their 
plasticity. The development of a 3D microenvironment that mimics the 
tumor ECM, inducing tumor cells plasticity, has been required to 
provide a novel screening 3D platform to test anticancer drugs on the 
distinct stages of tumor plasticity. We propose to combine IKVAV 
peptide with bacterial nanocellulose (BNC) hydrogels to develop an 
ideal 3D model that induces human melanoma, SK‒MEL‒28 cells, 
plasticity. IKVAV peptides were chemically immobilized on BNC 
hydrogels. BNC and BNC‒IKVAV hydrogels were characterized by 
different surface microstructures related to top and bottom of those 
hydrogels. The cytotoxic assay showed that the presence of IKVAV 
peptides do not interfere on the non cytotoxic potential of BNC 
hydrogels. Additionally, BNC-IKAV hydrogels improved the adhesion 
and proliferation of SK‒MEL‒28 cells on their top and bottom surfaces. 
While BNC hydrogels induced SK‒MEL‒28 cells to organize 
themselves as tumoroids, BNC‒IKVAV hydrogels induced the 
mesenchymal and amoeboid movements of SK‒MEL‒28 cells. On the 
bottom surface of BNC-IKAV hydrogels SK‒MEL‒28 cells formed 
well-established networks related to vasculogenic mimicry. Finally, our 
results showed that BNC and BNC‒IKVAV hydrogels could be used as 
3D platforms that allow the screening of the effect of antitumor drugs on 
the different mechanisms of metastasis.  
Keywords: Bacterial nanocellulose; IKVAV; human melanoma cells; 
tumor cells plasticity; vasculogenic mimicry. 
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4.1 INTRODUCTION 
Melanoma is an aggressive form of skin cancer derived from 
pigment-producing cells called melanocytes. Although melanoma 
accounts for only 1% of all skin cancers, it is responsible for 
approximately 80% of all skin cancer-related death [1]. According to the 
World Health Organization [2], about 132,000 new cases of melanoma 
are diagnosed worldwide each year. One of the most important 
parameter that affects the prognosis of melanoma patients is metastasis 
[3]. Tumor metastasis involved a multistep process which allow tumor 
cells dissemination from their primary site to form secondary tumors 
into others tissues and organs. The first stage of tumor metastasis has 
been denominated as tumor cells invasion [4]. Invasive melanoma cells 
usually changes their cytoskeletal morphology to become motile and 
able to degrade the surrounding extracellular matrix (ECM) to initiate 
the tumor invasion stage [5]. Melanoma cells are highly plastic and they 
change their pathway of invasion according to the three‒dimensional 
(3D) microenvironment that surrounding them. The surrounding ECMs 
regulate the metastatic cascade of tumor cells [6].  
There are two main pathways of cancer cells invasion that have 
been described: single tumor cell migration or collective tumor cells 
migration, which determines how the tumor cells through extracellular 
matrix barriers [7]. Single tumor cell can be using mesenchymal 
movements, which are characterized by the elongation of the 
cytoskeletal, or/and amoeboid movements that are characterized by a 
rounded shape [8]. Tumor cells when in mesenchymal movements 
penetrate the surrounding-ECM using subcellular structures called 
invadopodia that degrades the EMC by cell–matrix contact points [9]. 
When in amoeboid movements tumor cells externalize cell protrusions 
that regulates cytoskeleton. Those tumor cell protrusions has 
denominated as blebs and they usually are positioned on plasmatic 
membrane of tumor cells [9, 10].   Collective tumor cells invasion has 
been characterized by the migration of an entire group of tumor cells [7] 
that organize themselves as clusters, branches, as narrow linear strands 
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or sheets in an integrated movement that are associate with 
mesenchymal and/or amoeboid movements [11].  
In other kind of tumor plasticity, aggressive melanoma cells 
organize themselves as vascular channels through a mechanism 
independent of the tumor angiogenesis, a phenomenon denominated 
vasculogenic mimicry that refers to the plasticity of aggressive tumor 
cells to form vascular networks [12]. To construct a vascular mimicry 
network, tumor cells acquire particular characteristics normally 
restricted to endothelial cells concerning a well-defined vascular-like 
structures responsible to conduct blood to supply the tissue oxygen 
demand and also to allow the invasive process (metastasis) [12–14]. 
Invasive mechanisms of tumor cells by vascular mimicry development 
are still not completely understood which compromise the discovering 
of novel effective drugs to prevent cancer progression and invasiveness 
[15, 16]. 
Actually, anticancer drug effectiveness has been examined 
using two‒dimensional (2D) culture plates which not reproduce 
accurately the in vivo tumor microenvironment [17]. 3D culture 
platforms have been used to overcome the limitations of 2D culture, 
owing to their great potential of mimicking the tissue microenvironment 
in vitro [18, 19]. The most used 3D platforms to study tumor behavior in 
the concerning of metastasis, plasticity and tubulogenesis and 
vasculogenic mimicry are natural ECM, such as Matrigel® [20, 21] or 
Geltrex® [22]. These natural ECM are examples of commercial purified 
EMC extracted from tumor murine, where major components are 
laminin, collagen IV, entactin, heparin sulfate proteoglycans and others 
unknown components. Generally, commercial ECMs often generate 
inconsistent data which is related to their chemical variability and 
instability recurrent from batch to batch [22, 23]. 
Hydrogels have been used as scaffolds for 3D in vitro tests 
because their structures hold high water content associated with 
particular mechanical properties that resemble those of natural tissues 
[24]. Furthermore, hydrogels can be used to deliver soluble or 
immobilized signaling molecules to cells, acting as a support structure 
for cell growth and functionalization [25]. Bacterial nanocellulose 
(BNC) is a hydrogel secreted by Gluconacetobacter hansenii bacteria 
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with hydrophilic nanofibers that resemble native ECM [29]. The 3D 
porous structure of BNC gives it unique properties such as water 
retention capacity, mechanical strength and biocompatibility [26]. It has 
been established that the cell–biomaterial response influences the 
microarchitecture of the scaffold surfaces, such as porosity, fiber 
network structure, surface topology and fiber density [27–29]. When 
BNC hydrogels were produced under static conditions, two distinct 
surfaces are formed [30, 31]. The surface that comprises the air/liquid 
interface has a higher fiber density (top surface) and the opposite surface 
revealed lower fiber density (bottom surface) [31,32].  
Absorption or immobilization of bioactive peptides such as, 
collagen, fibronectin and laminin, have been used as an approach to 
increase cell adhesion on hydrogels surfaces [33]. Laminin have been 
associated with tumor vasculogenic mimicry formation and their 
absence reduces the expression of genes associated with the plasticity of 
melanoma cells [34]. Furthermore, peptides, such as laminin plays an 
important role in cell adhesion, migration, proliferation, neurite 
outgrowth, and angiogenesis [35]. IKVAV (isoleucine, lysine, valine, 
alanine, valine) laminin-α1 chain peptide has been related as a potent 
stimulator of tumor growth, metastasis, protease activation/secretion and 
angiogenesis [36–39].  Additionally, IKVAV peptide has been reported 
as endothelial cell migration and tubular network formation which 
happens through the interaction with unknown receptor at tumor cell 
surface [40–42]. 
To date, many studies have been focused on the use of BNC 
hydrogels as a delivering drug platform for many kinds of cancer 
treatments [43–45]. However, the best of to our knowledge, there were 
no studies addressed to the use of BNC hydrogel to understand the 
behavior of melanoma cells on a 3D microenvironment. Here, we 
propose the immobilization of IKVAV peptide on BNC hydrogels to 
explore the influence of the microstructure and the chemical surface 
properties on the behavior of human melanoma cells (SK‒MEL‒28). 
The relationship between the distinct microenvironments, top and 
bottom surface, of BNC‒IKVAV hydrogels may be fundamental to 
induce particular tumor cells behavior related to tumor metastasis 
stages, such as vasculogenic mimicry and invasive cell morphology. 
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4.2 EXPERIMENTAL 
4.2.1 Materials 
Reagents and chemicals were purchased from Sigma-Aldrich do 
Brasil Ltda. (São Paulo, SP) and Thermo Fisher Scientific do Brasil 
Ltda. (São Paulo, SP), unless otherwise stated. Water was distilled and 
deionized using an EASYpure II water purification system, series 1305, 
at 18 MΩ of resistance (Thermo Fisher Scientific). IKVAV (Ile-Lys-
Val-Ala-Val) peptide was synthetized by Genome Biotechnologies (Rio 
de Janeiro, RJ) and your identification and purity (>95%) was confirmed 
by HPLC-MS. 
4.2.2 Preparation of BNC hydrogels 
Gluconacetobacter hansenii, ATCC 23769 obtained from 
"Coleção de Cultura Tropical (CCT)", Fundação André Tosello, 
(Campinas, SP) was used to produce BNC hydrogels. G. hansenii was 
cultured in mannitol medium (25 g⋅L-1), yeast extract (5.0 g⋅L-1) and 
peptone (3.0 g⋅L-1), adjusted to pH 6.5 and sterilized. One hundred 
microliter of inoculum were added in mannitol agar plates. Mannitol 
agar plates were incubated at 26 °C for five days. Thirty single colonies 
were randomly selected and inoculated into 6 mL of mannitol medium. 
Subsequently, a solution composed by inoculum and mannitol medium 
(1:9) was stirred and transferred to 24 wells plates (1 mL/well). After 
four days of incubation, BNC hydrogels produced under static 
conditions at 26 °C were     carefully removed and purified with 0.1 M 
NaOH solution at 50 °C for 24 h and finally rinsed with distilled water 
to pH 6.5. 
4.2.3 Fabrication of BNC‒IKVAV hydrogels 
BNC hydrogels were oxidized with HNO3/H3PO4-NaNO2 
following the procedure described by Kumar and Yang (2002) [46]. 
Briefly, a solution of nitric acid (68% v/v) and phosphoric acid (85% 
v/v) were prepared (2:1 ratio) and BNC hydrogels (50 samples) were 
submersed in 45 mL of the acid solution. Carefully, 0.63 g of sodium 
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nitrite was added and the solution was kept at room temperature during 
24 h, in the absence of light. After that, BNC hydrogels were transferred 
to 0.2% (w/w) glycerol solution (15 min) to remove the residual part of 
the previous oxidative reaction. BNC hydrogels were finally washed 
with    acetone and air-dried for 30 min at 60 °C. Oxidized BNC 
hydrogels were immersed in 45 mL of 0.02 M MES (4-
morpholineethanesulfonic acid monohydrate) containing 0.01 M of 
EDC ((1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) (pH 4.0–4.5), 
during 24 h at 4 °C [47]. Oxidized BNC, hydrogels were washed with 
deionized water and immersed in 20 mL of 0.1 mg⋅mL-1 IKVAV 
aqueous solution at 4 °C for at least 24 h. BNC‒IKVAV hydrogels were 
washed with PBS buffer three times and rinsed with deionized water. 
Samples were lyophilized at -50 °C and    sterilized by UV light during 
30 min for in vitro tests. 
4.2.4  Characterization of BNC‒IKVAV hydrogels 
4.2.4.1  Chemical characterization of BNC‒IKVAV hydrogels  
BNC and BNC‒IKVAV hydrogels were chemically analyzed 
using Fourier Transformed Infrared Spectroscopy (FTIR). Infrared 
spectra were recorded on an Agilent spectrophotometer (model Carry 
600), with a resolution of 4 cm
-1
, in the range of 4000-600 cm
-1
, using 
attenuated total reflectance.  
4.2.4.2 Microstructural characterization of BNC‒IKVAV 
hydrogels 
Scanning electron microscopy (SEM) was performed to analyze 
the microstructure of BNC and BNC‒IKVAV hydrogels surfaces. BNC 
and BNC‒IKVAV hydrogels were characterized using a JEOL JSM-
6390LV microscope operated at 10 kV. Prior to analyses, freeze-dried 
samples were cut into small pieces and coated with a thin layer of 
sputtered gold.  
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4.2.4.3 Characterization of the surface area, pore volume and 
distribution of pore diameter of BNC and BNC‒IKVAV 
hydrogels 
Nitrogen adsorption–desorption at 77 K was conducted with a 
liquid nitrogen trap according to the principle of static volumetric 
method for BNC and BNC‒IKVAV hydrogels by a Quantachrome 
NovaWin version 10.01. The surface area (SA) was calculated by 
Brunauer-Emmett-Teller (BET) model and pore volume (PV) and 
distribution pore diameter (PD) were calculated by Barrett–Joyner–
Halenda (BJH) model. 
4.2.4.4 Detection of primary and secondary amines on 
BNC‒IKVAV hydrogels 
Ninhydrin assay, described by Moore and Stein (1968), was 
used to verify the presence of amine groups on the surface of 
BNC‒IKVAV hydrogels [48]. Ninhydrin (4 g) were dissolved in 15 mL 
of DMSO and 5 mL of 4 M acetate buffer (pH 5.2) were added. Samples 
(1.91 cm
2
) were submersed in a ninhydrin solution and incubated at 80 
°C for 30 min protected from light. After 15 min of heating, 100 µL of 
ethanol 50% were added as stabilizing agent to the solution. Then the 
absorbance was measured at 570 nm. A standard curve of IKVAV was 
prepared to analyze the results. 
4.2.5 Cell culture 
Immortalized murine fibroblast cell line (L929) and 
immortalized human melanoma cells SK‒MEL‒28 were cultured in 
DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 
10% FBS and 1% penicillin/streptomycin. Immortalized human 
umbilical vein endothelial cells (HUVEC) were maintained in RPMI-
1640 medium supplemented with 10% FBS, 1% penicillin/streptomycin. 
Cell cultures were maintained in a humidified CO2 (5% in air) incubator 
at 37 °C. All cells were cultured in culture plate until reaching 80% of 
confluence. Confluent cells were dissociated with trypsin, and 
centrifuged for 2-3 min. L929 cells were used between passages 16 and 
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18, HUVEC cells between passages 51 and 53 and SK‒MEL‒28 cells 
between 10 and 20. 
4.2.6 Cytotoxicity assay 
Cytotoxicity assay was performed with L929 murine fibroblast 
cell line cultured in direct contact with BNC and BNC‒IKVAV 
hydrogels following ISO standard 10993-05 guidelines for direct testing 
of medical devices [49]. L929 cells were seeded in a 24 wells plate in a 
density of    9 × 10
3
 cells⋅cm-2 during 24 h and they were kept in a 
humidified atmosphere containing 5% CO2 at 37 °C. After incubation, 
BNC and BNC‒IKVAV hydrogels were added into each well. At the 
end of 1, 3 and 7 days, samples and culture medium were removed and 
the adhered cells were rinsed with PBS three times. Metabolic activity 
was determined by mitochondrial activity through MTS [3-(4, 5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium] colorimetric assay from Promega Biotecnologia do 
Brasil, Ltda. (São Paulo, SP). MTS assay was performed according to 
the manufacturer’s instructions. Three hundred and sixty microliters of 
culture medium and MTS (5:1) were added on each well of a 24 wells 
plate where L929 cells were adhered. Culture plates were kept in a 
humidified 5% CO2 incubator at 37 °C      protected of light during 2 h 
for the MTS reaction. The metabolic activity of L929 cells were 
quantified by Micro ELISA reader, at a wavelength of 490 nm.  
4.2.7 Adhesion, proliferation and morphology of SK‒MEL‒28 
cells on BNC and BNC‒IKVAV hydrogels 
SK‒MEL‒28 cells were seeded on top and bottom surfaces of 
BNC and BNC‒IKVAV hydrogels in a density of 5.2 × 10
4
 cells⋅cm-2. 
After that, SK‒MEL‒28 cells were kept during 4 h to allow cell 
adhesion and during 1, 2, 3 and 7 days to evaluate cell proliferation. 
Cells were incubated at 37 °C with 5% of CO2. A MTS assay kit was 
used to quantify the adhesion and proliferation of SK‒MEL‒28 cells 
over 7 days.  MTS colorimetric assay was performed as previous 
described on Section 2.6.  
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To analyze cell behavior and morphology, SK‒MEL‒28 cells 
were stained with 4',6-diamidino-2-phenylindole dihydrochloride 
(DAPI) and Alexa Fluor 546 conjugated with phalloidin. SK‒MEL‒28 
cells were previously fixed with 4% formaldehyde for 30 min and 
permeabilized with 0.1% Triton X-100 for 5 min at room temperature. 
Phalloidin and DAPI were used to stain F-actin and nuclei, respectively. 
Images were taken using a confocal laser scanning microscopy (CLSM) 
Leica Microsystems (model DMI6000 B).  Morphology of adhered 
SK‒MEL‒28 cells on top surface and bottom surface of the hydrogels 
(BNC and BNC‒IKVAV) were evaluated after 24 h of cultivation, and 
compared to SK‒MEL‒28 cells cultured on 2D culture plate under the 
same conditions. 
4.2.8 Vasculogenic mimicry induction 
SK‒MEL‒28 cells were seeded (10
5
 cells⋅cm-2) on bottom 
surface of BNC‒IKVAV hydrogels and incubated for 24 and 48 h 
within a humidified incubator containing 5% of CO2 at 37 °C. As 
control, SK‒MEL‒28 cells were seeded on Geltrex® matrix (LDEV-
Free Reduced Growth Factor Basement Membrane Matrix, Thermo 
Fisher Scientific). The performance of Geltrex
®
 was tested with 
HUVEC cells prior to use as positive control. After 24 and 48 h of in 
vitro culture, SK‒MEL‒28 cells were fixed with 4% of formaldehyde 
for 30 min at room temperature. Phase contrast images were taken using 
an Olympus BX4 microscope (Olympus America Inc.).  The WimTube 
software (Wimasis Image Analysis) was used to analyze and quantify 
the covered area, tube length, branching points and loops of vascular 
mimicry tube networks.  
4.2.9 Statistical analysis  
Statistical analysis were performed by the method one-way 
analysis of variance (ANOVA) with Tukey test. P < 0.05 was 
considered significant. The results were expressed as the mean ± 
standard error. All experiments were run in triplicate at two separated 
times. 
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4.3 RESULTS 
4.3.1 Chemical immobilization and microstructural 
characterization of BNC and BNC‒IKVAV hydrogels 
BNC and BNC‒IKVAV hydrogels were successfully 
synthesized and standardized for all assays. To immobilize the IKVAV 
peptide, BNC hydrogels were oxidized with HNO3/H3PO4-NaNO2 to 
convert the free hydroxyl groups of BNC to carboxyl groups. 
HNO3/H3PO4–NaNO2 mediated the oxidative reaction that was initiated 
by α-hydrogen atom abstracted from C6 of BNC by such odd-electron 
species of NO2 and NO, giving as product BNC-COOH (Fig. 1a). The 
advantages of using HNO3/H3PO4–NaNO2 as oxidative agent of 
polysaccharides were related to the high selectivity and yield [46]. After 
activating the carboxyl groups of oxidized BNC hydrogels with EDC, 
IKVAV was covalently bonded onto the carboxyl now present in BNC 
hydrogels. The reaction between the amino groups of IKVAV and the 
carboxyl groups of BNC was represented in Figure 1b. 
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Figure 01. Immobilization reaction of IKVAV in BNC hydrogels. a) 
Oxidation process with HNO3/H3PO4-NaNO2 to convert the free hydroxyl 
groups of BNC to carboxyl groups, resulting in oxidized BNC (BNC-ox). b) 
Activation of the carboxyl groups present on the BNC-ox with EDC 
(coupling agent). Followed by the covalent reaction between active carboxyl 
groups on BNC-ox and the amine groups of the IKVAV peptide, resulting in 
BNC-IKVAV hydrogel. 
 
 
FTIR analysis showed the characteristic spectrum of BNC and 
BNC‒IKVAV hydrogels which supports the effectiveness on the 
functionalization of BNC with the IKVAV peptide (Fig. 2). BNC FTIR 
spectrum showed characteristic bands of BNC, where the absorption 
band assigned to the hydroxyl group and hydrogen bond observed at 
3345 cm
−1 
[50]. BNC‒IKVAV FTIR spectrum showed a group of 
characteristic bands of amide I appeared in the 1623 cm
−1
. An amide 
group in the L-sheet conformation gives rise to bands between 
approximately 1620 and 1640 cm
-1
 in the amide I region [50]. The 
absorption peaks between 2700–3000 cm
−1
 are characteristic bands of 
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NH3
+
, NH2
+
 or NH
+
 stretchings. These results indicate the presence of 
IKVAV immobilized on BNC hydrogels. 
 
Figure 2. FTIR spectroscopy of BNC and BNC-IKVAV. FTIR spectra of BNC 
with characteristic groups hydroxyl (OH) and alkanes (CH). BNC-IKVAV 
with characteristic groups amines (NH
+
, NH2
+
, NH3
+
), amide I (N-C=O) and 
hydroxyl (OH). 
 
The microstructure of the bottom and top surfaces of BNC and 
BNC‒IKVAV hydrogels were analyzed by SEM micrographs (Fig. 3). 
The microstructure of BNC hydrogels was characterized by 3D network 
structure characteristic. The bottom surface of BNC hydrogels were 
characterized by a 3D nanofiber network with random assembled 
nanofibers and interconnected pores (Fig. 3a). The top surface of BNC 
hydrogels were characterized by an entangled arrangement of nanofibers 
within no significant porous (Fig. 3b). SEM micrographs of the bottom 
surface of BNC‒IKVAV hydrogels showed that the nanofibers kept 
randomly  arranged containing some granules related to the peptide 
(IKVAV) immobilization over the nanofibers network (Fig. 3c). Similar 
granules were observed in a previous work [51] when collagen peptide 
was immobilized on dialdehyde BNC hydrogels. Those arrangements of 
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nanofibers and granules observed on the bottom surface of 
BNC‒IKVAV hydrogels were not observed on the top surface of 
BNC‒IKVAV. Top surface of BNC‒IKVAV hydrogels kept the same 
fiber arrangement observed on the top surface of BNC hydrogels (Fig. 
3d). Additionally, Brunauer-Emmett-Teller (BET) results showed that 
the immobilization of IKVAV altered pore volume (PV) and surface 
area (SA) of BNC hydrogels. SA and PV results were shown in Table 1. 
SA and PV of BNC‒IKVAV hydrogels increased 25 % and 28 %, 
respectively, compared to BNC hydrogels. BNC and BNC‒IKVAV 
hydrogels showed a similar distribution of pore size with diameters in a 
range of 3.4‒30.3 nm to BNC and 3.3‒28.5 nm to BNC‒IKVAV, 
respectively.  
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Figure 3. SEM micrographs of BNC and BNC-IKVAV hydrogels. a) Bottom 
surface BNC hydrogel, b) Top surface BNC hydrogel, c) Bottom surface BNC-
IKVAV hydrogel and d) Top surface BNC-IKVAV hydrogel. 
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Table 1. Surface area (SA) and pore volume (PV) of BNC and BNC-IKVAV 
hydrogels. 
 
Amine groups were identified on the surfaces of BNC‒IKVAV 
hydrogels by ninhydrin assay. Ninhydrin bound to amine groups present 
on the surface of the hydrogels produce a purple pigment that was 
detected by spectrophotometry at 570 nm. According to the standard 
curve, the equivalent amount of IKVAV immobilized on the BNC 
hydrogels was 18 μg⋅cm-2 (1.87% w/w). Our results showed an efficient 
immobilization of IKVAV when compared to results obtained by Liu et 
al. (2005) that used the same method to immobilize collagen on 
polyacrylonitrile (PAN) membranes. In that work they immobilized 
collagen in a density of 6.5 μg⋅cm-2 [47]. 
4.3.2 Cytotoxicity 
BNC hydrogels have been defined in the literature as a no 
cytotoxic biomaterial for tissue engineering applications [52]. To assess 
if the immobilization of IKVAV peptide on BNC hydrogels could affect 
the cytotoxic potential of BNC hydrogels in mammalian cells we 
performed a cytotoxicity test. The results obtained by MTS assay 
showed that BNC and BNC‒IKVAV  hydrogels did not induce any 
cytotoxic response on L929 cells after 7 days of culture, following the 
guide to cytotoxicity tests in vitro for medical devices ISO 10993-5: 
2009-[49]. After 1, 3 and 7 days of in vitro culture, BNC‒IKVAV 
hydrogels improved the metabolic activity of L929 cells in 103%, 123% 
and 104%, respectively, compared to BNC hydrogels (100%) (Fig. 4).  
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Figure 4. Metabolic activity of L929 cells after direct contact with BNC and 
BNC-IKVAV during 7 days. * Significantly different, P<0.05. 
 
4.3.3 Adhesion, proliferation and morphology of SK‒MEL‒28 
cells on BNC and BNC‒IKVAV hydrogels 
MTS assay was also used to determine the influence of the 
chemical and the microstructure surfaces of BNC and BNC‒IKVAV 
hydrogels on SK‒MEL‒28 cells adhesion and proliferation after 4 h, 1, 
2, 3 and 7 days (Fig. 5). After 4 h of culture, the metabolic activities of 
SK‒MEL‒28 cells increased when they were cultured on the bottom 
surface of BNC‒IKVAV compared to the bottom surface of BNC. The 
results showed that in the early contact (4 h) between cells and hydrogel 
surfaces there were 85% more adherent SK‒MEL‒28 cells on the 
bottom surface of BNC‒IKVAV, than on the same surface of BNC 
(100%). From 1, 2, 3 and 7 days, the metabolic activity of SK‒MEL‒28 
cells increased when they were cultured on bottom surface of 
BNC‒IKVAV compared to the bottom surface of BNC hydrogels. The 
increasing of metabolic activity of SK‒MEL‒28 cells were 55, 58, 20 
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and 272% for 1, 2, 3 and 7 days, respectively. SK‒MEL‒28 cells also 
adhered and proliferate more on the top surface of BNC‒IKVAV 
compared to the top surface of BNC. In this case, the increasing of 
metabolic activities were 221, 65, 74, 98 and 132% to 4 h, 1, 2, 3 and 7 
days, respectively. The top surface of BNC and BNC‒IKVAV induced 
SK‒MEL‒28 cells proliferation more than the bottom surfaces of the 
same biomaterials. After 1 day of culture there were no statistic 
differences on cell adhesion and proliferation comparing the bottom 
surface of BNC and top surface of BNC. An increasing of cell 
proliferation on the top surface of BNC in comparison to the bottom 
surface of BNC hydrogels was of 12, 13 and 125% considering 2, 3 and 
7 days, respectively. Additionally, the top surface of BNC‒IKVAV 
increased the tumor cells proliferation compared to the bottom surface 
of BNC‒IKVAV (21, 22, 87 and 40% for 1, 2, 3 and 7 days of 
cultivation, respectively).  
Figure 5. Adhesion and proliferation of SK‒MEL‒28 cells cultured on top and 
bottom surfaces of BNC and BNC‒IKVAV hydrogels during 7 days of in vitro 
culture. 
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The cells–hydrogels interaction was investigated by confocal 
microscopy after 4 h, 1, 2, 3 and 7 days. SK‒MEL‒28 cells were seeded 
on both surfaces of BNC and BNC‒IKVAV hydrogels. The presence of 
single cells was predominant during the early stages (4 h) of in vitro 
culture on the bottom surface of the BNC (Fig. 6a). On the top surface 
of BNC hydrogels, small clusters of SK‒MEL‒28 cells had already been 
formed after 4 h of culture (Fig. 6f). SK‒MEL‒28 cells adhered over 
both surfaces of BNC. However, the top surface of BNC had a greater 
number of proliferative cells (Fig. 6g-j) compared to the bottom surface 
of BNC (Fig.6b-e). SK‒MEL‒28 cells cultured on both surfaces of BNC 
organized themselves as tumor-like masses or tumoroids. SK‒MEL‒28 
cells formed tight cellular tumoroids ranging 30 to 100 µm of diameter 
when cultured on BNC surfaces. The diameter average presented was 
the average of 20 tumoroids/day. Tumoroids numbers were counted 
from full images considering the total surface of each hydrogel. 
Rounded aggregates of size ≥ 30 µm were counted as tumoroids. 
Tumoroids numbers were estimated from full confocal images of 
SK‒MEL‒28 cultured on BNC hydrogels surface considering the total 
surface of each hydrogel. Rounded aggregates with size ≥ 30 µm were 
counted as tumoroids. 
SK‒MEL‒28 cells showed a completely different behavior 
when they were cultured on BNC‒IKVAV. After 4 h of culture, 
adherent SK‒MEL‒28 cells showed rounded shape, typical of the early 
stages of the cellular adhesion, without the formation of clusters on both 
surfaces of BNC‒IKVAV (Fig. 6k, p). On the top surface of 
BNC‒IKVAV there were more adherent SK‒MEL‒28 cells (Fig. 6q-t) 
compared to the bottom surface of the same hydrogel (Fig. 6l-o). 
SK‒MEL‒28 cells proliferate on the top surface of BNC‒IKVAV 
maintaining the rounded shape over 7 days of in vitro culture. From 3 to 
7 days of culture it was possible to observe multilayers of SK‒MEL‒28 
cells on the top surface of BNC‒IKVAV (Fig. 6s, t). SK‒MEL‒28 cells 
cultured on the bottom surface of BNC‒IKVAV organize themselves in 
a network arrangement with elongated phenotype from 24 h to 3 days of 
in vitro culture (Fig.6l-n). On the second and third days, those cells were 
self-organized and elongated and they maintained cell-cell contact, 
building a secondary mechanism for tumor re-vascularization, known as 
vascular mimicry (Fig. 6m, n). SK‒MEL‒28 cells remained proliferative 
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until day 7 of culture when they became more connected (higher 
density) and shape rounded (Fig. 6o). 
Figure 6. CLSM images of SK‒MEL‒28 cells cultured on top and bottom 
surfaces of BNC and BNC‒IKVAV hydrogels. SK‒MEL‒28 cells were 
stained with Alexa Fluor 546 conjugated to phalloidin (red) and DAPI (blue). 
SK‒MEL‒28 cells were cultured on bottom and top surface of BNC and 
BNC-IKVAV hydrogels during 4h, 1d, 2d, 3d and 7d. 
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SK‒MEL‒28 cells morphology, after 24 hours of culture on 
BNC and BNC‒IKVAV were analyzed by confocal microscopy 
(CLSM) (Fig. 7). SK‒MEL‒28 cells cultured on both surfaces of BNC 
showed similar rounded morphology (clusters). The cell clusters formed 
presented rounded morphology with several blebs on their plasmatic 
membrane (Fig. 7a, b) which could be related to an invasive stage of 
tumor cells progression. Cell-cell adhesion in was observed on 
tumoroids formed on BNC hydrogels. SK‒MEL‒28 cells cultured on 
the top surface of BNC‒IKVAV showed rounded morphology with 
blebs or protusions formation after 24h of culture (Fig.7d). However, as 
SK‒MEL‒28 cells were not organized in cell clusters or tumoroids and 
their morphology has been associated with amoeboid movements [53]. 
When SK‒MEL‒28 cells were seeded on the bottom surface of 
BNC‒IKVAV, those cells presented an elongated shape with 
cytoskeletal protrusions known as invapodia (Fig. 7c). The presence of 
invapodia has been related with mesenchymal movements, other form of 
plasticity of the invasive tumor cells. However, the formation of blebs 
was also present in SK‒MEL‒28 cells cultured on bottom surface of 
BNC‒IKVAV. SK‒MEL‒28 cells grown on culture plates and showed 
elongated shape without any protuberances on their plasmatic 
membrane (Fig. 7e), typical morphology of melanoma cells when 
cultured on 2D culture. 
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Figure 7. CLSM images of SK‒MEL‒28 cells morphology cultured during 
24h on a) bottom surface of BNC hydrogels, b) top surface of BNC 
hydrogels, c) bottom surface of BNC‒IKVAV hydrogels, d) top surface of 
BNC‒IKVAV hydrogels and e) 2D-tissue culture plate. Red arrows indicate 
protuberances on the SK‒MEL‒28 cells cytoplasm: a, c and d indicate blebs 
and b indicate blebs and invapodia. SK‒MEL‒28 cells were stained with 
Alexa Fluor 546 conjugated with phalloidin (red) and DAPI (blue). 
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4.3.4 Vasculogenic mimicry induction 
SK‒MEL‒28 cells cultured on the bottom surface of the 
BNC‒IKVAV were able to interconnect their selves on networks. When 
10
5
 cells⋅cm-2 SK‒MEL‒28 cells were seeded on the bottom surface of 
BNC‒IKVAV, they were able to form well‒established networked like-
endothelial vessels. After 24 h of in vitro culture, SK‒MEL‒28 cells 
induced an alignment with phenotype characteristic of endothelial cells 
on tubulogenesis process, with the presence of tip and stalk cells (Fig. 8) 
and the development of branching points and loops (Fig. 9).  
Figure 8. Phase contrast images of SK‒MEL‒28 cells in the vascular mimicry network 
formation. SK‒MEL‒28 cells cultured on the bottom surface of BNC‒IKVAV 
hydrogels during 24h. Red arrows indicate tip cells. Stalk cells were signalized by 
rings. Scale bars represent 100 µm. 
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Figure 9. Phase contrast images of SK‒MEL‒28 cells in the vascular mimicry 
network formation. SK‒MEL‒28 cells cultured on the bottom surface of 
BNC‒IKVAV hydrogels during 24h.  Red dots indicate branching points and 
the loops are represented by rings. Scale bars represent 100 µm. 
 
 
When SK‒MEL‒28 cells were culture on Geltrex
®
, a 
commercial ECM, they were not able to form a well-organized vascular 
network, forming badly finished tubes and tumoroids. Unlike, Geltrex
®
 
was able to induce HUVEC cells tubulogenesis (Fig. 10a), but not 
vasculogenic mimicry by SK‒MEL‒28 cells (Fig. 10b), as observed on 
the bottom surface of BNC‒IKVAV (Fig. 10c). Vasculogenic mimicry 
network formed on the bottom surface of BNC-IKVAV showed 373 ± 
28 tubes, 196 ± 13 branching points and 63 ± 5 loops after 24 h of 
culture; and 458 ± 43 tubes, 246 ± 18 branching points and 87 ± 18 
loops after 48 h of culture (Fig. 11a, b). However, there were no 
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statistical differences (P<0.05) in the analyzed parameters comparing 
24h to 48h of SK-MEL-28 vasculogenic mimicry network formation.  
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Figure 10. Phase contrast images of a) SK‒MEL‒28 cells cultured on the 
bottom surface of BNC‒IKVAV hydrogels, b) SK‒MEL‒28 cells cultured 
on Geltrex matrix, and c) HUVEC cells cultured on Geltrex matrix, as 
positive control. SK‒MEL‒28 and HUVEC cells were cultured during 24 h 
on the referred materials. Scale bars represent 100 µm. 
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Figure 11. Phase contrast images of: a and b) SK‒MEL‒28 cells cultured on the 
bottom surface of BNC‒IKVAV  hydrogels, b and c) SK‒MEL‒28  cells 
cultured on the bottom surface of BNC‒IKVAV  hydrogels analyzed by 
WimTube software. SK‒MEL‒28 and cells were cultured during 24 h. Scale 
bars represent 50 µm.  
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4.4 DISCUSSION 
The plasticity of tumor cells has been related as dependent of 
the 3D microenvironment where those cells are growing [54]. Tissue 
microstructure and biochemical composition are important factors that 
have determined the tumor behavior and progression [55, 56]. Several 
efforts have been done in the development of an artificial and 
reproductive 3D microenvironment that resembles tumor ECM to 
understand the strategy of the tumor progression that requires blood 
vessels to access oxygen and nutrients and also to become invasive and 
metastatic. In this context, we successfully developed a 3D platform 
based on BNC immobilized with IKVAV peptide that simulated the 
tumor ECM inducing the plasticity of SK‒MEL‒28 cells present on 
aggressive cancers. It has been well established in the literature that 
tumor cells-ECM interactions cannot be replicated using 2D culture 
methods and the effect of antitumor drugs should be tested on 3D 
culture platforms [57].   
In this work, IKVAV peptide was chemically immobilized on 
BNC hydrogels and performed the physicochemical characterization of 
a novel BNC‒IKVAV hydrogels was also platform performed. There 
were particular characteristics related to the chemistry and 
microstructure of the top and bottom surfaces of BNC and 
BNC‒IKVAV that resembled the in vivo microenvironment in different 
plasticities of tumor development. SK‒MEL‒28 cells were able to 
adhere and acquire phenotypes of tumor cell invasiveness on the both 
surfaces (top and bottom) of BNC and BNC‒IKVAV hydrogels.  
SK‒MEL‒28 cells were more proliferative and metabolically 
active when they were cultured on BNC‒IKVAV than on BNC. Our 
results showed an improvement of twice in cell adhesion, comparing the 
bottom surfaces of BNC‒IKVAV to BNC. On the top surface, the 
increasing on cell adhesion was three times higher when SK‒MEL‒28 
cells were cultured on BNC‒IKVAV compared to BNC. In a previous 
work [58], IKVAV have been absorbed on BNC hydrogels to improve 
the adhesiveness, but those authors do not immobilized the peptide. 
Pertile and co-authors (2012) improved 100% the adhesion of 
pheochromocytoma rat cells on BNC adsorbed with IKVAV compared 
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to pure BNC hydrogels. However, on that work, the authors not 
mentioned which surface of BNC hydrogels were used to seed rat cells 
[58]. 
Our results also showed that the immobilization of IKVAV 
peptide influenced SK‒MEL‒28 proliferation. SK‒MEL‒28 cells 
proliferate higher on the BNC-IKVAV that BNC hydrogels. When 
comparing the same hydrogel, the top surface of BNC-IKVAV provided 
greater proliferation than the bottom surface of BNC-IKVAV. 
Recent reports have claimed that differences on the 
microstructure of the BNC hydrogels interfere directly on cell behavior. 
Berti and colleagues (2013) showed that HUVEC cells cultured on top 
and bottom surface of BNC hydrogels showed distinct behaviors [31]. 
Christopher et al. (2011) reported low adherence and proliferation when 
breast cancer cells were cultured on BNC hydrogels. The authors 
suggested that modifications on BNC surface would be necessary to 
improve the adhesion of tumor cells [59]. Our study corroborates the 
idea that the biomaterial microstructure determines cell behavior and it 
should be an important parameter to be considered on tissue engineering 
developments. Furthermore, our results suggest that the bottom surface 
of BNC‒IKVAV induced SK‒MEL‒28 cells follow amoeboid and/or 
mesenchymal pathways. Particularly, SK‒MEL‒28 cells form vascular 
networks, known as tumor cell vascular mimicry [14], after 24 h of in 
vitro culture on the bottom surface of BNC‒IKVAV.   
In tissue engineering and regenerative medicine applications, 
hydrogels have been highlighted because they hold a highly porous 
microstructure which provides an interconnected surface area that 
allows cell ingrowth [60, 61]. Porous surfaces have been related to cell 
and induction of neovascularization in 3D microenvironments [62]. That 
means that important parameters, such as pore size, pore volume, pore 
distribution, and surface area should be considered in the design of 
tissue engineering scaffold constructions. BNC and BNC‒IKVAV, with 
pores size ranging from 3.39 to 30.34 nm, may be classified as 
mesoporous hydrogels [63]. The differences on the microstructure of 
BNC hydrogels surfaces (top and bottom) have been previously reported 
and SEM results reinforced those findings [64–66]. BNC‒IKVAV 
showed an increase of 25% on surface area when compared to BNC. 
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This is in accordance with Joo et al., (2006) work that reported an 
increase on the surface area of cellulose performing the same oxidation 
reaction (HNO3/H3PO4-NaNO2) [67].  
Cancer cells have adapted their cell behavior on different 
microstructures assuming several morphologies and migration 
characteristics to move during the first stage of metastasis, cell invasion 
[7]. The development of a 3D platform that mimics tumor 
microenvironment, inducing tumor cell plasticity, is desired to 
identification studies of novel anticancer targets. Tumor cells migration 
and invasiveness has been classified based on their morphology on 3D 
hydrogels [53]. Generally, the invasiveness requires cell-cell adhesion 
[11] that usually has been related to a small cell clusters as observed on 
tumoroids formed on BNC hydrogels. SK‒MEL‒28 cells assumed 
tumoroid characteristics when cultured on the two surfaces of the BNC 
hydrogels, showing that on that microstructure the cell-cell interaction 
was greater than the cell-hydrogel interaction. After 24 h of culture, 
SK‒MEL‒28 tumoroids showed a typical morphology of amoeboid 
movements in collective invasion, containing several blebs around. In 
addition, the SK‒MEL‒28 tumoroids showed ideal size (30-100 μm) for 
use as cancer drugs screening platform [68–70]. When cells were 
cultured on top surface of BNC‒IKVAV, they also showed rounded 
shape containing several blebs around them, typical mechanism of 
amoeboid movements in singular invasion. Unlike, SK‒MEL‒28 cells 
cultured on the bottom surface of BNC‒IKVAV showed elongated 
morphology, typical of the mesenchymal movement of tumor invasion, 
In addition, cells with rounded shape and blebs were present on the 
bottom surface of BNC-IKVAV. Thus, SK‒MEL‒28 movements 
presented on the bottom surface of BNC‒IKVAV were not purely 
mesenchymal, but also amoeboid. SK‒MEL‒28 cells behavior when 
cultured on 2D culture plates were completely different from their 
behavior on BNC and BNC‒IKVAV hydrogels. Besides, our findings 
further support the concept that this 3D tumor platform mimics the in 
vivo tumor microenvironment. 
SK‒MEL‒28 cells behavior were characteristic of vasculogenic 
mimicry [13] when cultivated on the bottom surface of BNC-IKVAV. 
After 24 h, SK‒MEL‒28 cells were aligned and formed networks 
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similar to endothelial cells on angiogenesis. SK‒MEL‒28 cells with 
similar shape and behavior of endothelial cells in angiogenesis process 
(tip and stalk cells, loops and branching points) were also present. We 
used Geltrex
®
 as a positive control to perform our experiment. However, 
Geltrex
®
 was not able to induce vasculogenic mimicry on SK‒MEL‒28 
cells. We compared vascular mimicry networks formed by SK‒MEL‒28 
after 24 and 48 h of culture on the bottom surface of BNC‒IKVAV and 
quantified their main characteristics of vascular tube formation, such as 
number of tubes, branching points and loops (the usual characteristics 
quantified in the tubulogenesis assays). We found no significant 
differences between the number of tubes, branching points or loops 
formed after 24 and 48 h of culture on bottom surface of BNC‒IKVAV. 
These results suggest that 24 h of SK‒MEL‒28 cells culture would be 
enough to the evaluation of anticancer drug test against vasculogenic 
mimicry using the bottom surface of BNC‒IKVAV hydrogel platform. 
Our results are very similar to those found in the literature for melanoma 
cells cultured on Matrigel
®
 forming vasculogenic mimicry networks [22, 
34, 71]. Commercial ECM, such as Matrigel
®
, are chemically complex, 
containing growth factors, proteins and other components [20]. BNC–
IKVAV hydrogels contain just one protein (laminin) though 
reassembling a competent ECM. We showed that laminin peptide 
associated with the particular microstructure of BNC hydrogels were 
able to induce vascular mimicry on the invasive human cancer cell. 
These results matched with the biological functions of laminin peptide, 
IKVAV, mentioned in the literature, as a peptide that improves adhesion 
and proliferation of cancer cells through the stimulation of tumor growth 
factor to achieve metastasis through vasculogenic mimicry [36], [72]–
[74]. This suggests that the biological properties of IKVAV were kept 
after the immobilization on the bottom surface of BNC hydrogels. In 
addition, the immobilization of IKVAV peptide might be more effective 
on the bottom surface of BNC than on the top surface of BNC 
hydrogels. 
We did not find other works in the literature proposing such to 
construct an ideal 3D environment to achieve vasculogenic mimicry for 
anticancer test platform. Our work is pioneering in the development of a 
vascular mimicry 3D platform. Future work will test the efficiency of 
BNC‒IKVAV in the screening of anti-tumor drugs on vasculogenic 
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mimicry events. Tumor cells involved in vascular mimicry have been 
related as non sensible to angiogenesis inhibitors [75]. BNC‒IKVAV 
hydrogels is an alternative in the discovery of effective cancer drugs 
able to block the vasculogenic mimicry process. Here, we developed a 
chemically well-defined vascular mimicry 3D platform based on 
BNC‒IKVAV that may be used to study more than one type of tumor 
cell plasticity hydrogels. 
4.5 CONCLUSION 
IKVAV peptide was chemically immobilized on BNC 
hydrogels. SK‒MEL‒28 cells behavior were dependent of the 
microstructure and chemical composition. BNC and BNC‒IKVAV 
hydrogels induced the plasticity of human melanoma (SK‒MEL‒28) 
cells. SK‒MEL‒28 cells cultured on top and bottom surfaces of BNC 
hydrogels formed tumoroids with rounded morphology of tumor cells 
similar to what have been found in a collective tumor cells invasion 
mechanism. When SK‒MEL‒28 cells were cultured on top surface of 
BNC‒IKVAV, they showed rounded morphology containing blebs on 
their plasmatic membranes which were related to amoeboid movements 
found in tumor cell invasion. SK‒MEL‒28 cells vascular mimicry was 
induced when they were cultured on the bottom surface of 
BNC‒IKVAV hydrogels. SK‒MEL‒28 cells in different mechanism of 
invasiveness plasticity were observed on BNC and BNC‒IKVAV 
hydrogels. The proposed 3D platforms could be used as an alternative to 
development of customized melanoma anticancer drugs screening. 
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5 CONCLUSÕES GERAIS 
A nanocelulose bacteriana é um biomaterial amplamente 
utilizado na área biomédica e engenharia de tecidos, devido suas 
propriedades e sua biocompatibilidade. Entretanto, pouco se tem 
explorado o uso deste material como plataforma para estudo do 
comportamento de células tumorais. Neste trabalho foram 
desenvolvidos biomateriais a base de nanocelulose bacteriana para 
mimetização do microambiente tumoral, afim de se criar plataformas 
que possam servir como triagem de fármacos na angiogênese e no 
mimetismo vasculogênico. 
Em síntese, podemos concluir que: 
A funcionalização dos hidrogéis de nanocelulose bacteriana 
com heparina e IKVAV foi realizada com sucesso. A imobilização 
dessas moléculas na superfície dos hidrogéis foi confirmada e os 
biomateriais sintetizados não apresentaram citotoxicidade. 
As células cultivas sobre os hidrogéis sintetizados (BNC-HEP e 
BNC-IKVAV) mostraram comportamentos dependentes da 
funcionalização e da estrutura dos biomateriais. 
BNC-HEP mostrou aumentar a adesão e proliferação de células 
endoteliais de veia umbilical humana (HUVECs). Além disso, o lado 
inferior do hidrogel BNC-HEP foi capaz de induzir a tubulogênese em 
HUVECs. Assim, BNC-HEP pode ser utilizada como plataforma para 
testes iniciais da angiogênese, como adesão, proliferação e 
tubulogênese, com a vantagem da interferência de apenas um tipo de 
molécula sinalizadora no biomaterial, heparina.  
BNC-IKVAV foi capaz de induzir várias plasticidades celulares 
em células de melanoma humano, SK-MEL-28. Quando essas células 
foram cultivadas sobre as plataformas BNC-IKVAV aumentaram a 
adesão e proliferação, comparadas ao hidrogel puro de BNC. 
Tumoroides foram formados quando células SK-MEL-28 foram 
semeadas sobre o hidrogel BNC puro. No lado superior de BNC-
IKVAV as células invasivas de melanoma apresentaram plasticidades 
características do processo de migração na metástase. O lado inferior de 
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BNC-IKVAV induziu mimetismo vasculogênico após 24 horas de 
cultura de SK-MEL-28.  
As plataformas desenvolvidas podem ser potencialmente 
utilizadas para superar as limitações das plataformas atuais em testes de 
triagem de fármacos para inibir a angiogênese, mimetismo 
vasculogênico e outras plasticidades tumorais Além disso, BNC, BNC-
HEP e BNC-IKVAV podem ser utilizadas como plataformas de estudo 
do comportamento celular. 
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